COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

PULM_PNEUMONIA_SEPSIS

pneumonia: An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, caused by an infection in one or both of the lungs (by bacteria, viruses, fungi, or mycoplasma.). Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints PNEUMONIA SEPTICHE_PNEUMONIA	81046
6. Filter based on genotype QC (FinnGen only)	81046

Control definitions (FinnGen only)

Control exclude: PULM_INFECTIONS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	PULM_PNEUMONIA_SEPSIS
CONTROL_EXCLUDE	PULM_INFECTIONS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	PNEUMONIA\|SEPTICHE_PNEUMONIA
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	81046	34510	46536
Unadjusted period prevalence (%)	16.79	11.76	20.52
Median age at first event (years)	63.12	57.55	67.26

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
24519: Matched controls
190321

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N02BE01

ATC

paracetamol; systemic, rectal

2.0

323.0

20172

133220

R03AC02

ATC

salbutamol; inhalant

2.3

323.0

14385

71854

AA1AD

NOMESCO Finland

CT of head and brain

2.4

323.0

4352

15815

R03DA04

ATC

theophylline; systemic, rectal

5.6

323.0

1149

1654

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.1

323.0

2123

5689

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.2

323.0

5611

16281

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

55.3

323.0

502

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.9

323.0

2748

3973

R03BA05

ATC

fluticasone; inhalant

2.3

323.0

4993

18808

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

15.3

323.0

976

513

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

5.0

323.0

1382

2235

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

4.8

323.0

2180

3817

N02AA05

ATC

oxycodone; systemic

3.6

323.0

2919

6901

J01FF01

ATC

clindamycin; systemic

2.1

323.0

6339

27609

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.0

323.0

3569

6224

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

323.0

4770

19944

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

323.0

5077

16603

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.7

323.0

2844

5156

J45.1

ICD-10 Finland

Nonallergic asthma

4.2

323.0

2123

4214

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

323.0

13596

72412

H02AB06

ATC

prednisolone; systemic

2.7

323.0

12244

51435

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.5

323.0

12151

34117

C07AB07

ATC

bisoprolol; oral

1.9

323.0

7955

37882

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

8.3

323.0

1779

1787

A41.9

ICD-10 Finland

Sepsis, unspecified

8.5

323.0

851

802

TDM10

NOMESCO Finland

Puncture of maxillary antrum

6.4

323.0

1066

1332

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

5.3

323.0

2316

3646

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

+∞

323.0

1638

R03BA02

ATC

budesonide; inhalant

2.2

323.0

4659

18018

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

1424.0

323.0

348

J01AA02

ATC

doxycycline; systemic

2.0

323.0

18079

112054

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

323.0

6075

27629

TPH07

NOMESCO Finland

Cathetrisation of artery

3.1

323.0

2059

5441

R50.9

ICD-10 Finland

Fever, unspecified

4.0

323.0

4304

9651

A02BC02

ATC

pantoprazole; systemic

1.9

323.0

14553

83063

H02AB07

ATC

prednisone; oral

2.5

323.0

3380

11612

UGC12

NOMESCO Finland

Flexible bronchoscopy

7.1

323.0

2044

2402

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.3

323.0

3789

10010

A28

ICPC

Limited function/disability NOS

3.3

323.0

2251

5649

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

+∞

323.0

456

N03AX16

ATC

pregabalin; oral

2.1

323.0

5234

22059

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

323.0

3231

9956

R02

ICPC

Shortness of breath/dyspnoea

2.9

323.0

2923

8402

48609

ICD-8 Finland

Pneumonia, unspecified

+∞

323.0

1148

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

338.2

323.0

430

J01MA12

ATC

levofloxacin; systemic

4.9

323.0

5688

11119

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

4.1

323.0

1481

2958

R96

ICPC

Asthma

2.9

323.0

2298

6458

TGC00

NOMESCO Finland

Bronchial lavation

10.9

323.0

815

598

J12.8

ICD-10 Finland

Other viral pneumonia

635.1

323.0

482

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.2

323.0

2832

7469

J45.9

ICD-10 Finland

Asthma, unspecified

3.6

323.0

5542

14122

R81

ICPC

Pneumonia

14.1

323.0

1507

881

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.4

323.0

2940

7234

C03CA01

ATC

furosemide; systemic

3.8

323.0

4912

11721

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.8

323.0

1352

2298

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

6.6

323.0

1132

1388

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

5.9

323.0

1976

2806

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.6

323.0

1381

2023

R03DC03

ATC

montelukast; oral

2.3

323.0

4449

16831

J01MA14

ATC

moxifloxacin; systemic

8.9

323.0

3882

3926

R06.0

ICD-10 Finland

Dyspnoea

2.8

323.0

5897

19364

J01FA06

ATC

roxithromycin; oral

2.2

323.0

10658

48708

I50.9

ICD-10 Finland

Heart failure, unspecified

6.3

323.0

1560

2024

A03

ICPC

Fever

2.1

323.0

4680

19425

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.0

323.0

12220

63184

N02AX02

ATC

tramadol; systemic, rectal

2.0

323.0

8931

42114

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

323.0

7316

32929

ZX120

NOMESCO Finland

Intravenous

3.0

323.0

2325

6461

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

158.5

323.0

5833

374

J18.9

ICD-10 Finland

Pneumonia, unspecified

122.8

323.0

17177

3547

J46

ICD-10 Finland

Status asthmaticus

9.3

323.0

1007

872

R4110

NOMESCO Finland

Physiotherapy

2.0

323.0

5904

26358

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

6.7

323.0

1688

2085

J01DB01

ATC

cefalexin; oral

2.0

323.0

19864

129803

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

323.0

6042

25883

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

4.2

323.0

5308

11873

JN4BD

NOMESCO Finland

Extensive body CT

3.0

323.0

2233

6213

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.6

323.0

2915

9437

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.3

323.0

6100

24120

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

7.1

323.0

1514

1741

R03BB04

ATC

tiotropium bromide; inhalant

5.9

323.0

2421

3455

XF400

NOMESCO Finland

ECG with 12 standard connections

3.2

323.0

3446

9221

J01CA04

ATC

amoxicillin; systemic

1.9

323.0

20627

139199

48509

ICD-8 Finland

Bronchopneumonia, unspecified

+∞

323.0

792

J01MA02

ATC

ciprofloxacin; systemic

1.8

321.9

7613

37964

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

+∞

320.4

339

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

13.5

318.6

606

356

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.3

318.0

3609

13468

A46

ICD-10 Finland

Erysipelas

2.8

316.6

2393

7164

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

138.4

315.5

369

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

313.9

3253

11606

WX892

NOMESCO Finland

Monitored bed care

3.5

313.7

1632

3752

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

9.2

311.5

717

623

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

311.1

4069

16184

N05CF01

ATC

zopiclone; oral

1.9

309.6

6476

30899

R05

ICPC

Cough

1.9

309.0

5579

25256

N05BA01

ATC

diazepam; systemic, rectal

2.4

301.2

3090

10947

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

4.5

301.0

1191

2136

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

+∞

298.6

316

A06AD11

ATC

lactulose; oral

2.6

293.9

2409

7552

J45

ICD-10 Finland

Asthma

2.6

291.3

2535

8221

J01FA09

ATC

clarithromycin; systemic

1.7

289.4

7913

40982

GD1AD

NOMESCO Finland

Thorax CT examination

5.1

285.9

1002

1577

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

285.9

5035

22483

R03AC12

ATC

salmeterol; inhalant

4.6

285.6

1103

1928

N05AH04

ATC

quetiapine; oral

2.0

285.0

4223

17633

J47

ICD-10 Finland

Bronchiectasis

14.6

284.3

524

285

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

279.4

8611

46086

N05AA02

ATC

levomepromazine; systemic

4.4

277.3

1116

2033

B01AA03

ATC

warfarin; systemic

2.7

276.6

2151

6524

N05BA04

ATC

oxazepam; oral

1.8

276.5

5778

27366

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

6.5

274.1

783

954

SPAT1255

SPAT

Intravenous administration of medicine

3.4

273.1

1471

3466

H02AB04

ATC

methylprednisolone; systemic

2.2

272.9

3310

12658

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

272.4

5567

26144

B01AB05

ATC

enoxaparin; parenteral

1.8

272.2

6011

28975

J01DA01

ATC

[U] cefalexin; systemic

1.6

270.5

14700

91420

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

159.8

263.7

305

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.3

262.0

1096

2072

I50.0

ICD-10 Finland

Congestive heart failure

7.6

261.6

676

711

SPAT1254

SPAT

Administration of medicine

2.2

260.4

3071

11575

R03AC03

ATC

terbutaline; inhalant

2.1

260.3

3554

14290

L28

ICPC

Limited function/disability (L)

2.3

258.2

2721

9719

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

258.0

3024

11362

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

255.6

9948

56372

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.3

253.2

1422

3455

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

+∞

253.2

268

J20

ICD-10 Finland

Acute bronchitis

2.5

252.3

2280

7516

N05CD07

ATC

temazepam; oral

2.6

251.5

2168

6962

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.5

251.3

2286

7562

J96.1

ICD-10 Finland

Chronic respiratory failure

17.4

249.0

429

195

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

246.7

4774

21888

R03BA01

ATC

beclometasone; inhalant

2.1

245.9

3240

12803

J45.8

ICD-10 Finland

Mixed asthma

5.0

242.3

862

1377

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

8.4

240.6

580

545

R05

ICD-10 Finland

Cough

1.9

240.5

4249

18839

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.1

240.5

3179

12568

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.6

240.3

2000

6289

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

30.4

238.3

348

N03AG01

ATC

valproic acid; systemic, rectal

2.9

237.2

1618

4503

Z51.5

ICD-10 Finland

Palliative care

4.4

231.0

921

1658

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

7.5

231.0

598

630

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

37.5

229.7

320

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

228.0

8658

48299

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

223.1

3889

17103

D64.9

ICD-10 Finland

Anaemia, unspecified

2.9

222.4

1508

4174

WX872

NOMESCO Finland

Intensive care

4.5

221.9

876

1561

N06AX11

ATC

mirtazapine; oral

1.6

220.7

6988

37065

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.7

220.4

1740

5296

N06AB04

ATC

citalopram; systemic

1.8

218.5

4983

23988

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

38.9

218.4

302

N05BA06

ATC

lorazepam; systemic, sublingual

3.5

217.3

1125

2559

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

215.1

2230

7857

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.5

213.9

1963

6497

WX002

NOMESCO Finland

Sedation and analgesia

1.9

213.9

3798

16790

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.7

212.9

1678

5097

SPAT1263

SPAT

Sampling

1.6

212.7

9609

55676

M79.6

ICD-10 Finland

Pain in limb

1.6

212.5

7721

42379

XG410

NOMESCO Finland

Flow-volume spirometry

4.0

211.8

955

1931

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

211.2

8042

44655

SPAT1262

SPAT

Handing over of treatment supplies

2.0

210.8

3049

12459

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

6.5

209.9

602

736

R53

ICD-10 Finland

Malaise and fatigue

1.8

209.6

4210

19409

C08CA01

ATC

amlodipine; oral

1.7

209.5

4965

24142

R06AE07

ATC

cetirizine; oral

1.5

208.5

11016

66114

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.3

207.9

610

769

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

25.8

207.0

315

XF600

NOMESCO Finland

Bloodpressure measurement

3.1

205.1

1288

3380

J01FA15

ATC

telithromycin; oral

2.2

204.7

2423

9079

R03AK08

ATC

formoterol and beclometasone; inhalant

3.7

203.0

995

2162

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.7

200.8

755

1278

J15.8

ICD-10 Finland

Other bacterial pneumonia

57.9

200.1

258

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

199.4

3759

16924

R11

ICD-10 Finland

Nausea and vomiting

2.5

199.4

1833

6063

4659X

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Unspecified site

+∞

199.2

211

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

199.2

2110

7502

M04AA01

ATC

allopurinol; systemic

2.9

198.6

1324

3618

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

198.5

4492

21481

R60.0

ICD-10 Finland

Localized oedema

2.4

197.0

1954

6722

J01FA10

ATC

azithromycin; systemic

1.5

194.6

14880

96318

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.9

194.3

1316

3633

A07AA02

ATC

nystatin; oral

2.9

194.0

1326

3682

A02BC01

ATC

omeprazole; systemic

1.7

194.0

5317

26903

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.5

193.8

756

1329

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

193.1

4080

19064

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

192.8

3008

12628

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.2

192.5

2340

8862

TKC20

NOMESCO Finland

Catheterisation of bladder

3.2

192.0

1130

2831

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

17.1

191.8

332

153

R03AC13

ATC

formoterol; inhalant

3.2

191.5

1138

2870

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.0

190.4

673

1065

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.3

189.4

1934

6744

L04AA06

ATC

mycophenolic acid; systemic

6.7

187.5

523

615

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.2

187.4

1082

2670

UJF32

NOMESCO Finland

Coloscopy

1.7

187.2

4590

22443

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

186.4

3298

14488

N03AX12

ATC

gabapentin; oral

1.9

185.6

3111

13400

N05AH03

ATC

olanzapine; systemic

2.6

185.6

1577

4989

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

4.0

185.5

812

1596

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.2

185.4

635

970

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.2

185.2

635

971

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.9

184.4

1289

3627

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

183.2

1806

6184

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

6.8

182.5

504

584

JN4AD

NOMESCO Finland

Body CT examination

2.8

180.9

1316

3798

127

Kela drug reimbursment

Transplant complication

8.3

179.6

436

414

TK800

NOMESCO Finland

Hemodialysis

7.3

179.0

472

511

WX882

NOMESCO Finland

High dependency care

5.2

178.7

607

918

N05AX08

ATC

risperidone; systemic

2.6

177.9

1497

4708

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.9

177.7

1186

3238

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

177.1

7522

42425

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.0

176.5

1122

2963

WZC30

NOMESCO Finland

Teaching

2.0

176.2

2594

10619

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

176.0

2229

8576

A04AA01

ATC

ondansetron; systemic, rectal

2.5

175.9

1550

5000

R51.80

ICD-10 Finland

Headache

1.8

175.5

3551

16304

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

175.4

3755

17560

ZXA00

NOMESCO Finland

Right side

1.7

172.2

4803

24297

R06.2

ICD-10 Finland

Wheezing

3.1

172.1

1052

2703

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

9.4

171.1

387

325

N05AH02

ATC

clozapine; systemic

4.8

171.0

625

1026

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

170.5

9438

56341

S18

ICPC

Laceration/cut

1.5

169.2

7868

45190

C03DA01

ATC

spironolactone; oral

2.5

168.8

1508

4898

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.2

168.6

1856

6696

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

168.0

2595

10810

T90

ICPC

Diabetes non-insulin dependent

1.8

167.1

3261

14769

A10BA02

ATC

metformin; oral

1.7

166.9

3879

18579

R95

ICPC

Chron obstructive pulmonary disease

7.0

166.9

453

512

L04AX01

ATC

azathioprine; systemic

2.9

166.8

1119

3063

R03BB01

ATC

ipratropium bromide; inhalant

4.6

165.7

636

1099

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.6

165.6

1346

4145

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.6

165.3

830

1836

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.5

165.2

862

1967

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

164.2

4746

24196

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.6

164.2

1312

4000

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.9

164.0

753

1544

A02BC05

ATC

esomeprazole; systemic

1.5

163.8

8202

47792

ZXA05

NOMESCO Finland

Left side

1.7

163.5

4455

22343

A10AE04

ATC

insulin glargine; parenteral

2.4

163.3

1498

4932

N06AX16

ATC

venlafaxine; oral

1.8

163.0

3535

16559

49300

ICD-8 Finland

Asthma, bronchiale

6.0

162.9

493

647

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

8.4

162.9

392

367

J96.0

ICD-10 Finland

Acute respiratory failure

18.4

162.6

274

117

WX110

NOMESCO Finland

Local anesthesy

1.5

162.2

16468

110726

P01AB01

ATC

metronidazole; oral, rectal

1.5

162.1

9280

55602

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

6.2

161.8

478

608

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.4

161.0

418

442

S97

ICPC

Chronic ulcer skin

3.5

160.1

825

1864

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.7

160.0

503

693

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

159.8

2033

7821

J86.9

ICD-10 Finland

Pyothorax without fistula

32.6

159.7

229

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.8

159.3

588

975

C09AA05

ATC

ramipril; oral

1.8

159.2

2985

13322

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

159.1

2419

10003

N30.0

ICD-10 Finland

Acute cystitis

1.8

158.8

3135

14234

H02AB02

ATC

dexamethasone; systemic

2.0

158.4

2239

8996

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

157.3

2917

12964

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

+∞

156.7

166

G47.3

ICD-10 Finland

Sleep apnoea

1.8

155.8

3458

16294

J15.7

ICD-10 Finland

Pneumonia due to Mycoplasma pneumoniae

41.5

155.5

212

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

13.0

155.2

299

181

ZXA10

NOMESCO Finland

Bilateral

1.8

155.2

3309

15397

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

5.0

154.4

543

854

N06AA09

ATC

amitriptyline; systemic

2.1

153.8

2052

8049

M05BA04

ATC

alendronic acid; oral

2.5

153.6

1321

4196

SPAT1229

SPAT

Assessment of need for aid

2.6

152.2

1270

3965

4829X

ICD-9 Finland

Other bacterial pneumonia, Bacterial pneumonia unspecified

+∞

151.9

161

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.5

151.5

778

1752

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.6

149.8

570

976

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.5

149.5

1308

4193

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

149.2

1363

4472

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

149.0

2212

9050

205

Kela drug reimbursment

Chronic hypertension

1.8

148.5

3217

15024

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

148.3

5827

31980

N03AE01

ATC

clonazepam; systemic

2.5

146.5

1250

3951

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.2

145.2

1626

5898

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.8

144.9

527

860

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

4.6

144.8

554

954

M05BX04

ATC

denosumab; parenteral

3.1

142.3

890

2321

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.9

142.2

646

1311

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

+∞

141.6

150

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

141.5

6825

39139

Z71.8

ICD-10 Finland

Other specified counselling

1.5

141.0

5460

29802

N03AX09

ATC

lamotrigine; oral

2.4

140.8

1309

4330

WX722

NOMESCO Finland

PEEP

3.5

140.4

740

1701

WW500

NOMESCO Finland

Blood transfusion

3.2

139.9

800

1957

R01AD08

ATC

fluticasone; nasal

1.5

139.7

6423

36431

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

139.5

3495

17026

M54.5

ICD-10 Finland

Low back pain

1.5

139.2

6961

40193

4809X

ICD-9 Finland

Viral pneumonia, unspecified

+∞

138.7

147

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.3

138.7

571

1058

B01AC04

ATC

clopidogrel; oral

2.3

138.6

1495

5323

WX730

NOMESCO Finland

Conventional respirator

7.1

137.6

369

410

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

137.4

1999

8103

R05FB02

ATC

cough suppressants and expectorants

1.5

137.2

7379

43227

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.5

137.1

392

477

C10AA01

ATC

simvastatin; oral

1.5

137.0

5254

28582

46309

ICD-8 Finland

Acute tonsillitis, Unspecified

+∞

135.9

144

XW000

NOMESCO Finland

Bone marrow biopsy

3.5

135.1

702

1595

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

134.8

3474

17045

R01AD09

ATC

mometasone; nasal

1.4

134.5

10516

66131

WF049

NOMESCO Finland

Radiotherapy of metastasis

4.2

134.3

563

1061

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.7

134.1

648

1387

XG466

NOMESCO Finland

Sleep oxymetry

3.8

133.7

620

1281

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

133.1

6326

36063

N05AF03

ATC

chlorprothixene; systemic

3.5

133.1

688

1557

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

25.2

132.9

203

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

+∞

131.2

139

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.0

129.2

828

2194

130

Kela drug reimbursment

Malignant tumour

2.5

129.2

1106

3498

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

7.3

128.8

337

361

L17

ICPC

Foot/toe symptom/complaint

1.5

128.6

5031

27425

H02AB09

ATC

hydrocortisone; systemic

3.9

128.2

586

1196

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.3

127.4

706

1686

L03AA02

ATC

filgrastim; parenteral

3.7

125.7

603

1283

R04.2

ICD-10 Finland

Haemoptysis

4.6

125.7

478

818

207

Kela drug reimbursment

Chronic arrhythmias

2.3

125.4

1319

4635

N06AB03

ATC

fluoxetine; oral

1.7

125.3

2886

13676

WW200

NOMESCO Finland

Immunization

3.5

124.8

634

1414

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

124.6

2339

10382

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.3

124.5

695

1667

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.0

124.1

782

2048

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.0

122.7

372

490

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.0

122.4

1658

6515

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

7.6

122.1

311

320

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.3

121.6

501

929

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.9

121.5

822

2257

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.6

121.4

999

3089

B03XA02

ATC

darbepoetin alfa; parenteral

6.5

121.2

343

412

C01DA14

ATC

isosorbide mononitrate; oral

2.6

121.1

1000

3097

B01AF02

ATC

apixaban; oral

2.5

121.1

1031

3249

N05AD01

ATC

haloperidol; systemic

3.9

121.1

551

1120

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.2

121.0

1385

5061

N06AX21

ATC

duloxetine; oral

1.8

121.0

2397

10825

C01AA05

ATC

digoxin; systemic

3.9

120.5

548

1113

R74

ICPC

Upper respiratory infection acute

1.4

119.9

7437

44506

H25.1

ICD-10 Finland

Senile nuclear cataract

1.8

119.9

2288

10203

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

119.5

1691

6761

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

6.3

119.3

345

427

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

118.6

6842

40364

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

118.5

2262

10087

A01AB09

ATC

miconazole; local oral

2.0

118.2

1747

7107

48099

ICD-8 Finland

Viral pneumonia

+∞

117.9

125

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.1

117.8

502

961

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

117.1

1295

4658

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

116.9

1094

3625

A02BA02

ATC

ranitidine; systemic

1.6

116.8

3210

15971

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

116.6

1334

4873

N04AA02

ATC

biperiden; systemic

4.2

116.6

490

926

R03AK11

ATC

formoterol and fluticasone; inhalant

3.5

116.4

591

1318

A02BC03

ATC

lansoprazole; oral

1.5

114.6

5253

29538

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

114.4

4706

25844

R5140

NOMESCO Finland

Monitoring the use of the aid

2.0

114.4

1611

6425

J01EA01

ATC

trimethoprim; systemic

1.5

114.2

5604

31959

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.7

113.9

838

2425

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

113.9

8003

48892

R03BA08

ATC

ciclesonide; inhalant

1.9

113.7

1756

7258

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.9

113.2

513

1039

E87.6

ICD-10 Finland

Hypokalaemia

3.4

113.0

596

1370

W19

ICD-10 Finland

Unspecified fall

2.0

112.8

1648

6669

N18.8

ICD-10 Finland

Other chronic renal failure

5.5

112.5

362

514

N07BB01

ATC

disulfiram; oral

2.8

111.5

789

2228

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.9

111.4

342

458

ZX108

NOMESCO Finland

Inhalation

13.4

110.8

210

123

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.9

110.7

396

635

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

318.4

110.7

123

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

110.6

3002

14865

I50.1

ICD-10 Finland

Left ventricular failure

4.8

110.4

404

664

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

5.5

110.4

357

510

SPAT1216

SPAT

Assessment of functional ability

1.8

110.2

2166

9739

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.2

109.9

1251

4555

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

109.9

6494

38362

A04

ICPC

Weakness/tiredness general

1.7

109.9

2571

12205

E66.8

ICD-10 Finland

Other obesity

2.1

109.8

1313

4888

R42

ICD-10 Finland

Dizziness and giddiness

1.6

109.5

3507

18130

J01.1

ICD-10 Finland

Acute frontal sinusitis

6.2

109.0

322

410

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

108.1

1427

5539

SPAT1301

SPAT

No procedures

1.4

108.0

6108

35754

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.5

107.7

941

3005

48601

ICD-8 Finland

More specifically, unspecified pneumonia and the pleural irritation caused by it

+∞

107.5

114

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.4

107.4

1007

3338

201

Kela drug reimbursment

Chronic cardiac insufficiency

4.4

107.3

428

769

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.7

107.3

794

2305

J01DA06

ATC

[U] cefuroxime; systemic

1.6

107.2

3083

15498

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.3

106.2

1116

3914

R60.9

ICD-10 Finland

Oedema, unspecified

2.6

105.8

847

2575

K08.3

ICD-10 Finland

Retained dental root

2.3

105.5

1102

3855

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.0

105.4

1459

5773

A01

ICPC

Pain general/multiple sites

2.0

104.8

1464

5815

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

104.4

1781

7626

EBA00

NOMESCO Finland

Extraction of tooth

1.4

104.0

7042

42557

N05AX12

ATC

aripiprazole; systemic

2.3

103.7

1036

3545

J18

ICD-10 Finland

Pneumonia, organism unspecified

9.3

103.6

234

197

N03AF01

ATC

carbamazepine; oral, rectal

2.4

102.3

926

3012

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

102.3

1763

7574

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

4.8

102.1

373

612

AN1

Coronary angiography

2.3

102.0

1011

3444

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.4

102.0

993

3354

Z49.1

ICD-10 Finland

Extracorporeal dialysis

7.9

101.9

254

253

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.3

101.8

1005

3419

N06AB06

ATC

sertraline; oral

1.7

101.5

2557

12378

SPAT1260

SPAT

Consultation of another employee

1.6

101.5

3378

17598

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

101.3

5302

30506

E0000UV

ATC

1.4

101.2

8719

54839

E86

ICD-10 Finland

Volume depletion

5.5

100.7

324

460

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

99.3

1390

5522

M25.5

ICD-10 Finland

Pain in joint

1.4

99.3

6069

35939

4630A

ICD-9 Finland

Acute tonsillitis[TONSILLITIS ACUTA]

+∞

99.1

105

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

98.9

2377

11350

SPAT1234

SPAT

Support of social functional capacity

2.7

98.8

721

2075

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.9

98.7

655

1775

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.8

98.6

361

594

S06.0

ICD-10 Finland

Concussion

1.8

98.3

1930

8661

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

50.3

98.3

129

A11CC03

ATC

alfacalcidol; systemic

4.4

97.9

392

707

N05AB03

ATC

perphenazine; systemic, rectal

2.6

97.8

765

2294

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

8.1

97.5

238

229

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

3.2

97.3

574

1434

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

97.2

1203

4542

L04AD01

ATC

ciclosporin; systemic

3.7

96.8

457

959

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.8

96.3

349

568

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

95.7

1616

6886

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

3.3

95.7

537

1294

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

95.5

5744

33867

SPAT1325

SPAT

Vaccination

1.4

95.4

6076

36198

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

94.7

957

3289

Z94.0

ICD-10 Finland

Kidney transplant status

6.8

94.7

260

300

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.7

94.5

448

944

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

6.3

94.5

275

344

R4120

NOMESCO Finland

Occupational therapy

2.1

94.2

1214

4661

XQ800

NOMESCO Finland

Prick test

1.8

94.1

1865

8387

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.0

93.3

409

804

A29

ICPC

General symptom/complaint other

1.8

93.2

1900

8619

H66.9

ICD-10 Finland

Otitis media, unspecified

2.0

92.3

1362

5520

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

92.3

1434

5927

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.8

92.2

1908

8696

A12BA01

ATC

potassium chloride; oral

3.6

92.0

455

993

X58

ICD-10 Finland

Exposure to other specified factors

1.6

91.9

2621

13101

C10AA05

ATC

atorvastatin; oral

1.4

91.7

4760

27254

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

3.8

91.6

421

864

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

8.8

91.4

213

190

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

91.3

1746

7758

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

5.5

91.1

292

413

UKC02

NOMESCO Finland

Cystoscopy

1.8

90.6

1726

7658

48298

ICD-8 Finland

Other bacterial pneumonia, Other

+∞

90.6

N06AA12

ATC

doxepin; systemic

2.3

90.5

944

3295

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

90.4

2425

11923

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

89.9

902

3091

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

89.7

1264

5028

M10.9

ICD-10 Finland

Gout, unspecified

3.1

89.7

540

1370

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

+∞

89.6

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

8.5

89.6

212

194

A08

ICPC

Swelling

2.6

89.4

696

2081

P01BA02

ATC

hydroxychloroquine; oral

1.8

89.4

1771

7960

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.1

89.3

1060

3925

C07AB02

ATC

metoprolol; systemic

1.6

89.2

2578

12923

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

6.5

89.2

251

300

R4190

NOMESCO Finland

Nutritional therapy

2.6

89.2

711

2154

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

88.7

768

2438

C09AA02

ATC

enalapril; systemic

1.6

88.4

2339

11453

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

88.4

1576

6839

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.1

88.3

1065

3974

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

88.0

2082

9874

A04AA02

ATC

granisetron; systemic, transdermal

2.0

87.8

1183

4622

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

87.8

12265

82352

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

87.7

1960

9144

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

87.3

2360

11623

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.6

87.0

701

2136

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.0

86.6

539

1399

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

86.5

1900

8816

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

86.3

1176

4617

L89

ICD-10 Finland

Decubitus ulcer and pressure area

7.5

86.2

222

233

L04AA01

ATC

[U] ciclosporin; systemic

4.2

86.0

353

653

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

85.9

1469

6281

J94.8

ICD-10 Finland

Other specified pleural conditions

6.6

85.7

240

285

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.4

85.7

449

1027

R33

ICD-10 Finland

Retention of urine

2.8

85.6

607

1715

A07AA09

ATC

vancomycin; oral

5.7

85.6

269

372

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.8

85.3

586

1623

J03.0

ICD-10 Finland

Streptococcal tonsillitis

2.8

85.3

619

1775

A10AE05

ATC

insulin detemir; parenteral

2.3

85.2

893

3124

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

85.1

3436

18645

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

7.3

84.7

221

237

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

84.4

1629

7254

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.3

84.0

458

1081

J01.4

ICD-10 Finland

Acute pansinusitis

15.8

83.8

148

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.4

83.7

766

2505

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

83.7

873

3048

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

83.6

2442

12265

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

83.5

1281

5263

N05AN01

ATC

lithium; oral

2.8

83.4

596

1693

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

83.3

1767

8105

4810A

ICD-9 Finland

Pneumococcal pneumonia[PNEUMONIA PNEUMOCOCCICA]

+∞

83.0

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

82.9

5225

30926

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

25.7

82.6

125

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

82.6

3145

16837

N19

ICD-10 Finland

Unspecified kidney failure

4.4

82.5

326

581

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.8

82.2

580

1634

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

82.0

8431

53969

B01AB10

ATC

tinzaparin; parenteral

2.0

82.0

1208

4888

N06AX03

ATC

mianserin; oral

2.2

81.9

892

3175

J02AC01

ATC

fluconazole; systemic

1.3

81.8

10265

67611

A12AA04

ATC

calcium carbonate; oral

5.3

81.6

269

394

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

81.6

1609

7212

SPAT1104

SPAT

Monitoring of emergency patient

2.0

81.4

1092

4257

A41.8

ICD-10 Finland

Other specified sepsis

6.0

81.2

243

316

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.7

80.3

386

824

A10BH01

ATC

sitagliptin; oral

2.0

80.2

1129

4489

D07AC01

ATC

betamethasone; topical

1.4

79.9

6433

39628

ZX112

NOMESCO Finland

Subcutaneous

3.4

79.8

423

977

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.6

79.8

388

836

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

79.8

4279

24563

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

8.8

79.7

185

164

XF404

NOMESCO Finland

Ambulatory ECG

1.9

79.6

1319

5572

R52.9

ICD-10 Finland

Pain, unspecified

1.8

79.6

1551

6922

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.1

79.6

335

635

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

79.5

904

3283

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.1

79.2

1022

3920

RS221

NOMESCO Finland

4.0

79.1

349

691

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

78.8

3677

20533

J43.9

ICD-10 Finland

Emphysema, unspecified

8.0

78.7

193

188

J01FA01

ATC

erythromycin; systemic

1.5

78.6

3484

19251

N18.0

ICD-10 Finland

End-stage renal disease

7.9

78.3

194

192

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

78.3

10795

71872

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

78.0

16003

112381

J01DC02

ATC

cefuroxime; systemic

1.9

78.0

1204

4956

S22.3

ICD-10 Finland

Fracture of rib

2.2

77.9

860

3083

WX402

NOMESCO Finland

General anaesthesia

1.5

77.7

3312

18150

L03

ICPC

Low back symptom/complaint

1.4

77.5

4871

28760

S29

ICPC

Skin symptom/complaint other

1.5

77.4

3032

16312

N05AA01

ATC

chlorpromazine; systemic, rectal

4.3

77.4

312

568

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

77.2

1914

9186

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

77.1

1859

8852

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

77.0

1369

5926

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.7

76.9

364

767

WF004

NOMESCO Finland

Palliative radiotherapy

4.7

76.9

284

473

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

5.9

76.7

234

312

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

76.7

1870

8932

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

76.7

6336

39138

R55

ICD-10 Finland

Syncope and collapse

1.8

76.7

1403

6134

V03AE01

ATC

polystyrene sulfonate; oral

8.5

76.7

182

168

P72

ICPC

Schizophrenia

3.3

76.2

416

983

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

76.0

1447

6408

49099

ICD-8 Finland

Bronchitis, unspecified

7.0

75.9

203

226

K78

ICPC

Atrial fibrillation/flutter

2.6

75.6

592

1777

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

75.4

1104

4455

K02.1

ICD-10 Finland

Caries of dentine

1.3

75.3

13215

90647

R29

ICPC

Respiratory symptom/complaint other

1.9

75.2

1228

5159

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.5

75.0

291

510

G44.2

ICD-10 Finland

Tension-type headache

1.5

74.8

2861

15303

R13

ICD-10 Finland

Dysphagia

2.0

74.6

988

3830

JN4CD

NOMESCO Finland

Very extensive body CT

2.7

74.5

546

1575

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

74.5

1692

7915

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

74.4

1563

7142

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

9.7

74.2

163

131

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

7.6

74.1

187

191

B34.9

ICD-10 Finland

Viral infection, unspecified

2.5

73.8

635

2009

4830A

ICD-9 Finland

Pneumonia due to other specified organism, Mycoplasma pneumoniae[PNEUMONIA E MYCOPLASMA PNEUMONIAE]

+∞

73.6

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

73.4

1023

4047

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.0

73.4

1051

4204

N06AB10

ATC

escitalopram; oral

1.4

72.9

4638

27397

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

72.8

2194

11085

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.3

72.4

724

2474

E87.5

ICD-10 Finland

Hyperkalaemia

7.0

72.4

193

214

E66.9

ICD-10 Finland

Obesity, unspecified

2.3

72.4

757

2643

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

72.4

1044

4187

137

Kela drug reimbursment

Uraemia requiring dialysis

7.7

72.3

182

185

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.4

72.1

644

2077

SPAT1252

SPAT

Overall medication plan or its review

2.1

71.9

909

3457

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

71.8

1394

6208

R07.3

ICD-10 Finland

Other chest pain

1.8

71.7

1461

6607

120

Kela drug reimbursment

Hypogammaglobulinaemia

34.2

71.7

101

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.6

71.6

586

1802

N07BA03

ATC

varenicline; oral

2.0

71.6

1031

4132

R41.0

ICD-10 Finland

Disorientation, unspecified

3.8

71.6

331

684

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

9.6

71.4

158

129

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

71.4

634

2040

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.9

71.2

255

411

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.9

71.2

176

174

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

70.8

749

2630

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

70.7

2131

10762

B03XA01

ATC

erythropoietin; parenteral

10.3

70.4

150

114

K07

ICPC

Swollen ankles/oedema

2.7

70.3

534

1573

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

3.0

70.2

440

1148

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

70.1

1158

4884

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.3

70.0

384

911

N05AC02

ATC

thioridazine; oral

2.9

70.0

457

1226

GBB00

NOMESCO Finland

Tracheostomy

7.0

69.6

187

210

XG460

NOMESCO Finland

Short time oxymetry

5.0

69.1

239

371

A10BH05

ATC

linagliptin; oral

2.9

68.9

464

1269

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

8.9

68.9

159

140

I50

ICD-10 Finland

Heart failure

5.7

68.8

215

296

M48.0

ICD-10 Finland

Spinal stenosis

1.7

68.7

1425

6481

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

61.6

68.6

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

6.6

68.6

191

226

M01AE02

ATC

naproxen; oral, rectal

1.3

68.5

12708

87280

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.9

68.3

1174

5019

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

68.2

8324

54172

N05BE01

ATC

buspirone; oral

2.5

67.9

561

1736

A10BB12

ATC

glimepiride; oral

2.5

67.7

596

1910

Z72.0

ICD-10 Finland

Tobacco use

2.7

67.6

516

1526

N05BA02

ATC

chlordiazepoxide; systemic

3.3

67.5

373

890

K92.1

ICD-10 Finland

Melaena

2.5

67.3

572

1797

SPAT1310

SPAT

Counselling related to known health issue

1.3

67.2

6414

40317

J01CA08

ATC

pivmecillinam; oral

1.3

67.1

10191

68188

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.7

67.0

318

672

TFP20

NOMESCO Finland

Cardiodefibrillation

2.3

66.9

649

2185

N05AF05

ATC

zuclopenthixol; systemic

4.7

66.8

244

402

C01CA24

ATC

epinephrine; parenteral

1.7

66.7

1415

6478

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.1

66.6

407

1044

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

22.5

66.4

104

RS220

NOMESCO Finland

3.9

66.4

301

612

R03DC01

ATC

zafirlukast; oral

3.7

66.3

315

667

0382A

ICD-9 Finland

Septicaemia, Pneumococcal septicaemia

+∞

66.0

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.7

65.8

482

1390

N05BA12

ATC

alprazolam; oral

1.6

65.8

1930

9671

N03AF02

ATC

oxcarbazepine; oral

2.4

65.8

607

1994

SPAT1097

SPAT

Recording of ECG

1.6

65.6

2061

10508

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.9

65.4

428

1150

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.1

65.4

783

2908

WX704

NOMESCO Finland

Intubation

1.8

65.4

1324

5973

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.1

65.3

388

976

UJD02

NOMESCO Finland

Gastroscopy

2.2

65.3

754

2758

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.7

65.2

472

1353

L01CA04

ATC

vinorelbine; systemic

6.7

65.0

178

206

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

5.6

64.7

203

281

L03AA13

ATC

pegfilgrastim; parenteral

2.1

64.6

804

3036

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

12.3

64.5

126

E000001

ATC

1.4

64.4

4287

25444

SPAT1058

SPAT

PEF monitoring instruction

1.7

64.3

1454

6784

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.0

64.1

403

1053

48199

ICD-8 Finland

Pneumococcal pneumonia

+∞

64.1

A01AB04

ATC

amphotericin B; local oral

2.1

64.1

752

2767

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

3.8

64.1

299

623

C08CA13

ATC

lercanidipine; oral

1.7

64.0

1592

7632

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.3

64.0

656

2267

C09CA01

ATC

losartan; oral

1.4

64.0

3200

18040

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

64.0

739

2700

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

63.7

4834

29301

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.0

63.7

849

3299

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

8.1

63.6

155

150

Z00.0

ICD-10 Finland

General medical examination

1.4

63.3

3363

19174

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

6.2

62.7

183

231

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

8.9

62.7

144

126

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

62.7

1382

6398

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

62.7

1007

4202

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

6.5

62.7

176

211

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

4.2

62.7

259

484

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

62.6

4643

28028

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

62.5

1021

4285

N06AB05

ATC

paroxetine; oral

1.7

62.2

1286

5838

M02AA07

ATC

piroxicam; topical

1.3

62.2

6221

39271

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.4

62.2

557

1801

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.8

61.9

423

1169

N03AX14

ATC

levetiracetam; systemic

2.7

61.8

461

1345

K59.0

ICD-10 Finland

Constipation

2.0

61.7

832

3246

SPAT1167

SPAT

Insertion of urinary catheter

4.0

61.6

267

522

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

30.1

61.5

H03AA01

ATC

levothyroxine sodium; systemic

1.3

61.3

4940

30197

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

61.2

2283

12104

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

11.9

61.2

121

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

61.2

740

2761

S76

ICPC

Skin infection other

2.0

61.0

822

3207

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

60.9

2062

10692

SPAT1211

SPAT

Application of soft bandage

1.6

60.9

1570

7597

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.1

60.7

365

927

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.2

60.6

350

863

N17.8

ICD-10 Finland

Other acute renal failure

6.8

60.5

164

187

F61.0

ICD-10 Finland

Mixed personality disorders

2.8

60.4

430

1218

U04

ICPC

Incontinence urine

2.2

60.4

637

2233

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

5.3

60.4

200

296

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

60.4

8040

52681

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

60.0

667

2397

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.1

59.8

359

911

R03CC02

ATC

salbutamol; systemic

1.6

59.7

1644

8094

A10AA02

ATC

2.5

59.7

520

1656

WVA20

NOMESCO Finland

Medicine administration

3.0

59.7

373

972

B01AB04

ATC

dalteparin; parenteral

2.1

59.3

742

2809

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

59.3

682

2489

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

59.2

1441

6862

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.2

59.2

684

2500

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.4

59.2

311

715

C90.0

ICD-10 Finland

Multiple myeloma

6.8

59.1

161

185

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.3

59.1

324

770

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

58.9

870

3519

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.8

58.8

400

1101

R04.0

ICD-10 Finland

Epistaxis

2.0

58.8

805

3159

A99

ICPC

Disease/condition unspecnature/site

1.7

58.6

1298

6016

JDB10

NOMESCO Finland

Percutaneous gastrostomy

5.6

58.5

184

256

A03FA02

ATC

cisapride; oral, rectal

1.8

58.5

1184

5338

H3603, E103

ICD-10 Finland

4.2

58.4

239

443

S72.0

ICD-10 Finland

Fracture of neck of femur

3.5

58.3

299

675

K92.0

ICD-10 Finland

Haematemesis

3.4

58.1

302

689

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.1

58.1

347

877

J16.8

ICD-10 Finland

Pneumonia due to other specified infectious organisms

90.8

58.0

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

4.3

57.6

230

416

C08CA02

ATC

felodipine; oral

1.9

57.4

933

3908

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.8

57.4

406

1148

U02

ICPC

Urinary frequency/urgency

1.5

57.3

2595

14319

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

57.3

1035

4496

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

57.3

597

2081

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

57.1

2049

10761

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.7

57.1

271

574

P99

ICPC

Psychological disorders other

2.2

57.0

630

2259

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.9

56.9

895

3705

P29

ICPC

Psychological sympt/compl other

1.7

56.9

1344

6347

J96.9

ICD-10 Finland

Respiratory failure, unspecified

11.5

56.8

114

J01CF05

ATC

flucloxacillin; systemic

2.2

56.7

623

2225

P15

ICPC

Chronic alcohol abuse

2.7

56.7

421

1226

C03AA03

ATC

hydrochlorothiazide; oral

1.7

56.5

1176

5349

M01AX17

ATC

nimesulide; oral

1.4

56.4

3877

23068

S10

ICPC

Boil/carbuncle

1.9

56.4

930

3915

V03AE02

ATC

sevelamer; oral

10.6

56.4

118

R01AD12

ATC

fluticasone furoate; nasal

1.3

56.2

6657

42871

ZZA00

NOMESCO Finland

Split skin graft

2.9

56.0

368

993

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.6

55.9

433

1293

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.0

55.9

813

3267

C07AA05

ATC

propranolol; systemic

1.3

55.8

4137

24916

D11

ICPC

Diarrhoea

1.5

55.4

2359

12852

D07AB08

ATC

desonide; topical

1.5

55.3

1997

10499

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.3

55.1

302

718

XG405

NOMESCO Finland

Education on PEF monitoring

3.5

55.1

281

632

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.4

55.0

287

657

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.1

55.0

187

286

B03BA03

ATC

hydroxocobalamin; parenteral

2.1

54.9

658

2444

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.1

54.9

653

2418

R10.0

ICD-10 Finland

Acute abdomen

2.2

54.9

581

2041

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.3

54.9

526

1761

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.2

54.8

593

2106

UDC00

NOMESCO Finland

Ear microscopy

1.7

54.8

1160

5303

SPAT1059

SPAT

Spirometry at the office

1.9

54.8

813

3295

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

54.6

733

2857

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.8

54.6

380

1064

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

8.1

54.5

132

127

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.8

54.4

386

1092

M03BX02

ATC

tizanidine; oral

1.2

54.4

13399

93893

C02AC05

ATC

moxonidine; oral

2.4

54.4

492

1600

Z50.1

ICD-10 Finland

Other physical therapy

1.9

54.4

882

3692

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3.6

54.3

265

575

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.8

54.2

252

525

T89

ICPC

Diabetes insulin dependent

2.1

54.1

684

2600

M05BA07

ATC

risedronic acid; oral

2.5

54.0

443

1365

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

53.9

1194

5530

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.4

53.8

507

1682

M01AH01

ATC

celecoxib; oral (coxibs)

1.4

53.8

3048

17539

J05AB01

ATC

aciclovir; systemic

1.3

53.7

4156

25176

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

53.7

5056

31527

N06AX12

ATC

bupropion; oral

1.6

53.6

1378

6658

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.8

53.6

192

311

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

3.1

53.6

321

812

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.0

53.2

753

2994

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.8

52.9

366

1020

SPAT1251

SPAT

Organisation of medication

2.3

52.9

513

1729

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.8

52.9

369

1034

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.4

52.8

481

1568

B05DA

ATC

Isotonic solutions

7.2

52.7

138

150

L04AX04

ATC

lenalidomide; oral

13.0

52.7

100

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.6

52.6

195

328

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

52.5

11934

82744

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

52.2

1035

4633

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

52.1

1208

5671

G72.8

ICD-10 Finland

Other specified myopathies

4.7

52.0

189

311

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

51.9

1879

9878

A07EC01

ATC

sulfasalazine; oral, rectal

1.6

51.7

1460

7232

A10AA01

ATC

2.4

51.6

482

1593

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.6

51.5

403

1212

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

6.0

51.2

153

200

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.1

51.2

310

792

NHQ40

NOMESCO Finland

Amputation of toe

5.3

51.2

168

247

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

3.2

51.1

295

728

WX320

NOMESCO Finland

Spinalanesthesy

1.3

51.1

3766

22624

D01

ICPC

Abdominal pain/cramps general

1.5

51.1

2233

12222

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

50.9

978

4332

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

50.9

2323

12820

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

3.2

50.9

296

735

M79.1

ICD-10 Finland

Myalgia

1.4

50.9

2482

13877

R09

ICPC

Sinus symptom/complaint

1.5

50.7

1679

8645

Z94.2

ICD-10 Finland

Lung transplant status

34.5

50.7

348

Kela drug reimbursment

Roflumilast

70.1

50.7

153

Kela drug reimbursment

Lenalidomid

10.9

50.7

104

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

50.7

2332

12893

SPAT1153

SPAT

Removal of sutures

1.3

50.7

5216

32882

EBA30

NOMESCO Finland

Excision of root of tooth

2.0

50.6

704

2782

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.4

50.6

262

597

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.4

50.5

481

1606

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

50.4

16441

118268

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.2

50.3

282

681

T82

ICPC

Obesity

1.9

50.3

794

3292

UDM02

NOMESCO Finland

Sinoscopy

2.8

50.2

351

986

R31

ICD-10 Finland

Unspecified haematuria

1.9

50.2

858

3656

R78

ICPC

Acute bronchitis/bronchiolitis

2.5

50.2

410

1262

D07AC13

ATC

mometasone; topical

1.3

50.2

5417

34360

XF402

NOMESCO Finland

ECG with work load test

1.6

50.1

1345

6571

N02AA01

ATC

morphine; systemic, rectal

7.3

50.1

129

137

X57

ICD-10 Finland

Unspecified privation

2.7

50.1

380

1122

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

6.9

50.0

134

151

TK810

NOMESCO Finland

Hemofiltration

8.7

50.0

116

104

L04AA13

ATC

leflunomide; oral

2.3

49.9

514

1784

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

49.9

8725

58656

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

5.1

49.8

169

258

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

4.4

49.8

195

347

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

49.8

1529

7731

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.8

49.7

343

955

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.6

49.6

395

1199

L14

ICPC

Leg/thigh symptom/complaint

1.7

49.6

1156

5434

E000003

ATC

1.8

49.5

871

3748

N05CF02

ATC

zolpidem; oral

1.4

49.4

3410

20259

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

49.4

1662

8588

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

4.0

49.4

215

423

S01.0

ICD-10 Finland

Open wound of scalp

1.8

49.3

862

3700

1240

FHL

Bronchoscopy

5.9

49.3

149

198

SPAT1240

SPAT

Therapeutic discussion

1.4

49.3

2528

14264

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

49.3

415

1300

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

5.3

49.3

163

242

WZA90

NOMESCO Finland

Other doctors statement

1.3

49.2

4744

29619

R52.2

ICD-10 Finland

Other chronic pain

2.1

49.1

586

2174

H01

ICPC

Ear pain/earache

1.4

49.1

2221

12231

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

49.1

4516

28011

F05.9

ICD-10 Finland

Delirium, unspecified

4.3

49.1

198

363

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

3.5

49.0

245

543

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

49.0

638

2455

XA800

NOMESCO Finland

Neuropsychological investigation

2.0

48.9

697

2779

J98.1

ICD-10 Finland

Pulmonary collapse

9.3

48.9

109

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

4.3

48.9

194

350

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.4

48.8

251

569

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

48.7

956

4265

I20.09

ICD-10 Finland

Unstable angina

2.5

48.7

423

1348

C08DB01

ATC

diltiazem; oral

2.5

48.4

422

1347

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.7

48.3

359

1047

RD210

NOMESCO Finland

2.6

48.2

371

1103

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

48.2

2081

11352

JAH00

NOMESCO Finland

Laparotomy

2.5

48.2

398

1234

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.0

48.1

208

407

R03DX07

ATC

roflumilast; oral

90.2

48.1

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.4

48.1

436

1420

J01

ICD-10 Finland

Acute sinusitis

1.7

48.0

985

4456

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

48.0

941

4197

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.7

48.0

1092

5096

J01MA06

ATC

norfloxacin; oral

1.4

48.0

2454

13836

Z49.2

ICD-10 Finland

Other dialysis

6.6

47.9

133

158

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

47.9

2834

16404

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

5.6

47.8

150

209

J05AB11

ATC

valaciclovir; oral

1.4

47.7

2461

13898

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.9

47.7

306

814

V03AA01

ATC

3.9

47.7

214

433

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.7

47.6

147

201

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

47.6

972

4389

R03BC01

ATC

cromoglicic acid; inhalant

2.6

47.5

368

1100

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

3.9

47.5

211

423

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.3

47.4

479

1647

-50

ICPC

Medication/prescr/renewal

2.0

47.4

635

2472

ZX100

NOMESCO Finland

Oral

3.7

47.4

223

470

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

47.4

1192

5723

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.0

47.3

694

2798

XKD00

NOMESCO Finland

Uroflowmetry

1.8

47.2

894

3942

J15.0

ICD-10 Finland

Pneumonia due to Klebsiella pneumoniae

+∞

47.1

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.5

47.1

238

532

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

47.1

938

4206

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

7.3

47.0

121

129

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

46.9

2192

12146

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

46.9

813

3482

A02BA04

ATC

nizatidine; systemic

1.7

46.8

1030

4759

J04.0

ICD-10 Finland

Acute laryngitis

1.9

46.8

712

2910

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

46.7

3480

20905

B02.9

ICD-10 Finland

Zoster without complication

1.8

46.7

806

3448

L15

ICPC

Knee symptom/complaint

1.3

46.7

3757

22836

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

4.4

46.6

183

327

F10.24

ICD-10 Finland

Alcohol depence active use

3.5

46.6

236

529

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

46.5

885

3908

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.6

46.5

361

1080

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

46.4

775

3278

J32.4

ICD-10 Finland

Chronic pansinusitis

3.5

46.4

234

523

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.4

46.3

411

1324

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.8

46.3

4609

43380

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

46.2

1350

6739

4661A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchiolitis

+∞

46.2

P03

ICPC

Feeling depressed

1.4

46.2

2216

12338

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

46.2

816

3517

N01

ICPC

Headache

1.4

46.0

2445

13874

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.9

46.0

296

789

TGA30

NOMESCO Finland

Thoracocentesis

9.2

46.0

103

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

9.7

46.0

100

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.0

45.9

606

2343

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.9

45.6

303

825

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

2.8

45.6

312

866

OAB43

SPAT

0.7

45.6

2584

26161

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

45.6

7149

47346

G41.9

ICD-10 Finland

Status epilepticus, unspecified

7.5

45.5

115

119

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.9

45.5

298

804

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

45.4

542

2009

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

8.2

45.3

108

102

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.0

45.2

155

240

196

Kela drug reimbursment

Paricalcitol and cinacalcet

9.3

45.2

101

TAB00

NOMESCO Finland

Lumbar puncture

1.8

45.2

817

3550

H25.8

ICD-10 Finland

Other senile cataract

1.8

45.1

840

3684

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

45.1

1358

6830

L12

ICPC

Hand/finger symptom/complaint

1.4

45.1

2697

15623

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

6.9

45.1

121

137

R03BB07

ATC

umeclidinium bromide; inhalant

5.9

45.0

136

181

L05

ICPC

Flank/axilla symptom/complaint

1.8

45.0

864

3825

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

45.0

511

1856

HA1AA

NOMESCO Finland

X-ray mammography

1.5

45.0

1601

8376

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.8

44.9

207

429

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.6

44.9

166

279

I25.2

ICD-10 Finland

Old myocardial infarction

2.7

44.9

326

938

WW300

NOMESCO Finland

Transfer of autologic stem cells

8.8

44.9

103

R01

ICPC

Pain respiratory system

2.7

44.8

319

908

S21

ICPC

Skin texture symptom/complaint

1.4

44.7

2038

11235

WX290

NOMESCO Finland

Other blockade of nerve

1.2

44.6

10307

71088

WYA20

NOMESCO Finland

Home visit

4.7

44.6

163

271

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

5.3

44.6

147

218

R01AD05

ATC

budesonide; nasal

1.5

44.5

1446

7407

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

44.5

625

2479

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

16.2

44.4

M01AB55

ATC

diclofenac, combinations; oral

1.7

44.4

958

4399

R04

ICPC

Breathing problem other

2.1

44.4

557

2111

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

44.4

2298

12978

4808X

ICD-9 Finland

Viral pneumonia, Pneumonia due to other virus not elsewhere classified

+∞

44.3

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.7

44.3

137

188

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.1

44.3

520

1915

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.6

44.3

357

1092

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

44.3

1170

5691

R21

ICPC

Throat symptom/complaint

1.3

44.3

4822

30539

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.2

44.2

249

605

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

44.2

397

1288

R28

ICPC

Limited function/disability (R)

4.0

44.2

192

378

U07

ICPC

Urine symptom/complaint other

1.8

44.2

871

3893

P76

ICPC

Depressive disorder

1.6

44.1

1407

7174

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

3.8

44.1

199

405

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.6

43.9

341

1021

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.1

43.9

517

1908

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.7

43.9

321

929

R06AE09

ATC

levocetirizine; oral

1.3

43.8

3127

18642

U71

ICPC

Cystitis/urinary infection other

1.6

43.7

1214

5982

N02AC04

ATC

dextropropoxyphene; oral

2.4

43.7

404

1329

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

372.0

43.6

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.7

43.6

330

974

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

43.6

1919

10502

A09AA02

ATC

multienzymes (lipase, protease etc.)

3.0

43.6

266

685

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.0

43.5

185

357

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.4

43.5

225

513

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.0

43.5

187

365

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.8

43.4

860

3846

RS222

NOMESCO Finland

3.5

43.4

216

478

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.9

43.1

682

2826

SPAT1312

SPAT

General health counselling

1.2

43.1

6655

43927

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.3

43.1

439

1516

R03BC03

ATC

nedocromil; inhalant

1.6

43.0

1272

6364

C01BD01

ATC

amiodarone; systemic

3.2

43.0

243

592

H26.3

ICD-10 Finland

Drug-induced cataract

5.3

42.9

140

205

N06AA06

ATC

trimipramine; systemic

2.3

42.9

442

1534

L84

ICD-10 Finland

Corns and callosities

2.2

42.9

479

1726

SPAT1324

SPAT

Screening procedure

0.8

42.8

3562

34304

D07AA02

ATC

hydrocortisone; topical

1.4

42.7

2782

16339

R52.0

ICD-10 Finland

Acute pain

2.0

42.7

571

2222

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.1

42.6

178

338

6BA02

NOMESCO Finland

8.5

42.6

100

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.1

42.6

506

1875

N05CD02

ATC

nitrazepam; oral

3.5

42.5

210

462

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

42.3

5409

34914

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.2

42.3

441

1541

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.1

42.3

492

1807

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.6

42.3

327

976

3AC01

NOMESCO Finland

3.7

42.2

200

425

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

4.8

42.1

150

243

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

4.9

42.0

148

237

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

7.5

42.0

106

110

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

41.9

3661

22483

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.4

41.9

162

286

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

41.8

1174

5797

E000006

ATC

1.6

41.8

1329

6772

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.8

41.7

291

817

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

41.7

12786

90408

T74.1

ICD-10 Finland

Physical abuse

2.3

41.7

405

1368

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

3.0

41.6

261

685

J37.0

ICD-10 Finland

Chronic laryngitis

2.1

41.6

512

1925

S01

ICPC

Pain/tenderness of skin

1.9

41.5

684

2877

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

4.8

41.5

148

240

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

41.4

1749

9487

SPAT1360

SPAT

Extensive global examination

1.6

41.4

1089

5291

C08CA05

ATC

nifedipine; systemic

1.8

41.3

763

3339

N05AB01

ATC

dixyrazine; systemic

3.8

41.3

190

394

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

41.3

1118

5472

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.7

41.3

853

3868

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

5.5

41.2

130

183

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

41.2

866

3945

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.5

41.1

1484

7782

B05DB

ATC

Hypertonic solutions

6.6

41.1

113

133

M01AB05

ATC

diclofenac; systemic, rectal

1.2

41.1

13501

96037

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.4

41.1

359

1149

J01DA08

ATC

[U] cefaclor; oral

1.3

41.0

2852

16919

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.1

41.0

487

1803

GDG10

NOMESCO Finland

Bilateral transplantation of lung

46.6

41.0

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

15.6

41.0

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.3

40.9

223

530

M01AH02

ATC

rofecoxib; oral

1.4

40.9

1882

10383

SPAT1053

SPAT

Memory test

1.6

40.8

1048

5057

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.6

40.8

323

979

J11.0

ICD-10 Finland

Influenza with pneumonia, virus not identified

6.3

40.8

116

143

J80

ICD-10 Finland

Adult respiratory distress syndrome

16.5

40.7

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.5

40.7

345

1086

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.5

40.7

342

1072

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.5

40.6

340

1061

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

40.6

671

2827

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.3

40.6

216

504

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.6

40.6

1087

5302

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.7

40.6

191

404

K77

ICPC

Heart failure

5.1

40.6

136

206

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.6

40.4

314

942

K65.0

ICD-10 Finland

Acute peritonitis

4.3

40.4

161

293

J02AC03

ATC

voriconazole; systemic

19.0

40.3

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.7

40.2

971

4607

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.1

40.2

491

1842

C08DA01

ATC

verapamil; systemic

2.0

40.1

523

2015

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.4

40.1

1961

10943

29599

ICD-8 Finland

Schizophrenia, Unspecified type

5.8

40.0

121

162

L29

ICPC

Musculoskeletal sympt/complt other

1.6

39.9

1260

6409

R5110

SPAT

2.4

39.8

360

1173

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.3

39.8

398

1363

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.6

39.8

306

913

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.0

39.7

169

327

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.1

39.7

468

1727

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

24.6

39.6

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.0

39.6

523

2024

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.7

39.6

185

389

L88

ICPC

Rheumatoid/seropositive arthritis

1.8

39.5

684

2929

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

39.5

737

3235

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.2

39.5

225

553

A06AH03

ATC

naloxegol; oral

4.1

39.5

166

318

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.4

39.4

2005

11273

R06AX13

ATC

loratadine; oral

1.3

39.2

3350

20488

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.4

39.2

367

1218

U05

ICPC

Urination problems other

2.0

39.2

522

2029

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.9

39.2

251

669

Z08

ICPC

Social welfare problem

3.0

39.1

244

637

EMB10

NOMESCO Finland

Tonsillectomy

1.6

39.1

1210

6121

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.3

39.1

374

1254

J01MA01

ATC

ofloxacin; systemic

1.6

39.0

1084

5339

I95.9

ICD-10 Finland

Hypotension, unspecified

4.0

38.9

167

326

D07AD01

ATC

clobetasol; topical

1.3

38.9

2684

15897

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.0

38.8

235

603

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

38.8

738

3259

S20.2

ICD-10 Finland

Contusion of thorax

1.8

38.8

659

2804

R75

ICPC

Sinusitis acute/chronic

1.7

38.8

905

4253

N06AX05

ATC

trazodone; oral

2.1

38.7

488

1854

P20

ICPC

Memory disturbance

1.7

38.7

839

3860

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.6

38.6

184

394

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

6.6

38.6

106

125

F34.1

ICD-10 Finland

Dysthymia

1.8

38.5

726

3198

Z00.8

ICD-10 Finland

Other general examinations

1.6

38.5

1195

6051

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.4

38.4

341

1099

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.8

38.4

268

754

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

44.1

38.4

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

4.1

38.4

161

308

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

38.3

2266

13084

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.1

38.3

467

1751

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.0

38.3

515

2009

C07AG02

ATC

carvedilol; oral

1.9

38.2

573

2331

F20

ICD-10 Finland

Schizophrenia

4.3

38.2

151

273

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.2

37.9

396

1386

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.4

37.9

2219

12784

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.6

37.9

294

881

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.3

37.9

151

275

Z72.2

ICD-10 Finland

Drug use

4.3

37.9

149

268

R07.1

ICD-10 Finland

Chest pain on breathing

2.8

37.9

260

724

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

37.8

731

3245

NF3AA

NOMESCO Finland

Femur X-ray examination

2.9

37.8

247

667

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.3

37.8

389

1352

4801A

ICD-9 Finland

Viral pneumonia, Pneumonia due to respiratory syncytial virus

+∞

37.7

L02

ICPC

Back symptom/complaint

1.4

37.7

1740

9602

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

7.9

37.6

D06

ICPC

Abdominal pain localized other

1.5

37.6

1549

8355

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.4

37.6

347

1142

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

3.4

37.5

196

452

5BA08

NOMESCO Finland

6.0

37.5

110

142

L95

ICPC

Osteoporosis

2.2

37.4

423

1533

N05BB01

ATC

hydroxyzine; systemic

1.5

37.4

1189

6058

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

37.3

673

2922

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

37.3

7273

49036

P18

ICPC

Medication abuse

4.6

37.3

139

237

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.6

37.0

1061

5266

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.4

36.9

328

1058

I95.1

ICD-10 Finland

Orthostatic hypotension

2.9

36.9

236

627

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.0

36.9

511

2018

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.8

36.8

254

710

ZX121

NOMESCO Finland

Central venous catheter

6.3

36.7

104

128

R09.1

ICD-10 Finland

Pleurisy

2.6

36.7

286

858

-1

NOMESCO Finland

1.2

36.7

7472

50574

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

5.5

36.6

115

162

N05AD03

ATC

melperone; systemic

3.9

36.6

162

326

E000002

ATC

1.4

36.6

2312

13491

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.0

36.6

221

567

Z29.0

ICD-10 Finland

Isolation

8.4

36.5

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

4.5

36.5

139

242

M54.8

ICD-10 Finland

Other dorsalgia

1.8

36.5

693

3060

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

18.7

36.5

D10

ICPC

Vomiting

1.5

36.5

1289

6725

I45.9

ICD-10 Finland

Conduction disorder, unspecified

5.2

36.4

121

182

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

7.3

36.3

N05AL01

ATC

sulpiride; systemic

2.7

36.3

260

744

RS230

NOMESCO Finland

5.1

36.3

123

189

1XC02

NOMESCO Finland

4.5

36.3

136

233

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

36.3

461

1757

L08

ICPC

Shoulder symptom/complaint

1.3

36.3

3013

18337

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.4

36.2

315

1006

N17

ICPC

Vertigo/dizziness

1.4

36.2

1613

8838

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

36.2

4963

32204

N03AX11

ATC

topiramate; oral

1.9

36.1

548

2240

B01AF01

ATC

rivaroxaban; oral

1.5

36.0

1286

6726

G04CA02

ATC

tamsulosin; oral

1.8

36.0

666

2915

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.5

36.0

293

904

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.9

36.0

156

308

R06AX27

ATC

desloratadine; oral

1.2

35.9

6084

40390

L16

ICPC

Ankle symptom/complaint

1.4

35.9

1859

10477

K90

ICPC

Stroke/cerebrovascular accident

2.9

35.8

236

641

J01GB01

ATC

tobramycin; inhalant, parenteral

159.3

35.8

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

5.2

35.8

118

176

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.5

35.8

309

983

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

35.7

1144

5837

A02BX02

ATC

sucralfate; oral

2.0

35.7

516

2073

H26.4

ICD-10 Finland

After-cataract

1.7

35.6

746

3397

4224

FHL

Endonasal anthrostomy

3.5

35.6

175

385

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

6.3

35.6

101

125

R01AD01

ATC

beclometasone; nasal

1.3

35.5

2787

16814

SPAT1281

SPAT

Other administrative function

1.5

35.5

1348

7145

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

35.5

490

1933

R06AX22

ATC

ebastine; oral

1.3

35.4

3536

22059

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.1

35.4

208

523

WX212

NOMESCO Finland

Femoral plexus blockade

2.9

35.4

234

638

WF002

NOMESCO Finland

Radical radiotherapy

2.1

35.3

445

1691

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.9

35.3

580

2437

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.4

35.3

1844

10406

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.9

35.3

539

2208

UJF92

NOMESCO Finland

Capsular endoscopy

2.3

35.3

356

1225

D12

ICPC

Constipation

2.1

35.3

420

1560

J42

ICD-10 Finland

Unspecified chronic bronchitis

3.5

35.2

174

384

F20.10

ICD-10 Finland

Raise schizophrenia continuously

5.6

35.2

110

154

A02BA03

ATC

famotidine; systemic

2.0

35.2

450

1721

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

35.1

1481

8028

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.2

35.0

397

1444

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

8.1

35.0

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.2

35.0

374

1322

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.2

34.9

374

1324

L86

ICPC

Back syndrome with radiating pain

1.6

34.9

882

4237

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

34.9

933

4551

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

34.8

2344

13809

P06

ICPC

Sleep disturbance

1.4

34.8

1803

10162

Z01.7

ICD-10 Finland

Laboratory examination

1.4

34.8

1856

10517

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.8

34.8

633

2756

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

8.0

34.7

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.0

34.7

215

561

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

6.7

34.7

109

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.1

34.7

413

1534

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

3.3

34.7

190

455

SPAT1172

SPAT

Guidance concerning hydration

3.2

34.7

195

475

GD2SN

NOMESCO Finland

Lung ventilation SPECT

5.5

34.6

109

154

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.6

34.6

169

370

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

34.6

2763

16708

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.0

34.6

470

1844

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

9.4

34.5

K10.3

ICD-10 Finland

Alveolitis of jaws

1.6

34.5

867

4157

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

34.4

1170

6049

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

6.9

34.4

102

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.7

34.4

163

348

J10.8

ICD-10 Finland

Influenza with other manifestations, seasonal influenza virus identified

33.9

34.4

R03AC18

ATC

indacaterol; inhalant

5.7

34.4

105

143

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

3.9

34.4

151

302

B81

ICPC

Anaemia vit B12/folate deficiency

2.1

34.4

411

1530

P01

ICPC

Feeling anxious/nervous/tense

1.3

34.2

2594

15565

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.2

34.2

193

472

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.9

34.2

223

603

N06AA04

ATC

clomipramine; systemic

2.4

34.1

314

1034

K99

ICPC

Cardiovascular disease other

2.7

34.1

249

720

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.9

34.1

523

2146

Angiography of the heart and coronary arteries

2.3

34.1

327

1100

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

9.6

34.0

N06AG02

ATC

moclobemide; oral

1.7

34.0

700

3171

R06.4

ICD-10 Finland

Hyperventilation

2.4

34.0

315

1040

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.8

34.0

576

2448

K93

ICPC

Pulmonary embolism

4.1

33.9

142

272

N18

ICPC

Paralysis/weakness

3.0

33.9

207

536

M81.4

ICD-10 Finland

Drug-induced osteoporosis

7.0

33.8

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.2

33.8

186

447

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

33.7

5518

36454

P19

ICPC

Drug abuse

3.0

33.7

204

524

K56.7

ICD-10 Finland

Ileus, unspecified

3.2

33.7

190

464

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.6

33.7

988

4934

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

33.7

594

2560

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

3.6

33.6

161

347

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.2

33.6

186

449

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.3

33.6

2787

16943

S92.3

ICD-10 Finland

Fracture of metatarsal bone

1.8

33.5

626

2750

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.7

33.5

679

3059

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.0

33.5

207

539

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

3.8

33.5

152

313

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

6.6

33.5

109

183

Kela drug reimbursment

Lamotrigin and topiramate

2.9

33.4

212

562

M03BX01

ATC

baclofen; systemic

2.4

33.4

291

931

G04BE03

ATC

sildenafil; oral

5.9

33.4

100

133

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

33.4

1937

11136

F20.5

ICD-10 Finland

Residual schizophrenia

5.1

33.3

112

171

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.2

33.3

187

455

L50.0

ICD-10 Finland

Allergic urticaria

1.9

33.2

488

1971

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

7.4

33.2

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.7

33.2

795

3762

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.3

33.2

315

1053

A10AE06

ATC

insulin degludec; parenteral

2.0

33.2

469

1868

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

33.1

3815

24212

H05BX01

ATC

cinacalcet; oral

6.7

33.1

105

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

5.0

33.1

114

179

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

33.1

445

1737

B82

ICPC

Anaemia other/unspecified

2.4

33.1

301

986

A10BK03

ATC

empagliflozin; oral

1.6

33.1

831

3986

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

9.3

33.1

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.0

33.1

209

552

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.8

33.0

150

309

Z94.1

ICD-10 Finland

Heart transplant status

17.8

33.0

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.3

33.0

330

1130

L01BC06

ATC

capecitabine; oral

1.9

33.0

482

1941

GD1UN

NOMESCO Finland

Lung circulation SPECT

5.6

33.0

102

141

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.9

33.0

543

2285

N06AX26

ATC

vortioxetine; oral

1.5

33.0

1083

5555

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

8.1

33.0

7803A

ICD-9 Finland

General symptoms, Convulsions

2.9

33.0

215

581

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.9

33.0

514

2123

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

9.5

33.0

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.6

32.9

160

349

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.3

32.9

180

431

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.4

32.9

1782

10124

M79.7

ICD-10 Finland

Fibromyalgia

1.7

32.7

688

3137

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

9.3

32.7

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

4.7

32.6

119

199

WNF00

NOMESCO Finland

Infection source and contact determination

8.1

32.6

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.7

32.6

118

196

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.0

32.5

138

268

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

32.5

2250

13308

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

3.4

32.4

170

394

TJD20

NOMESCO Finland

Change of gastrostomy tube

9.2

32.4

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

32.3

991

5004

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

3.8

32.3

145

296

S80.0

ICD-10 Finland

Contusion of knee

1.5

32.3

1166

6114

GDC00

NOMESCO Finland

Lobectomy of lung

7.3

32.2

J02.0

ICD-10 Finland

Streptococcal pharyngitis

2.3

32.2

330

1146

S72.1

ICD-10 Finland

Pertrochanteric fracture

4.0

32.2

136

263

I26

ICD-10 Finland

Pulmonary embolism

3.6

32.2

155

336

K85

ICPC

Elevated blood pressure

1.4

32.2

1822

10428

R40.2

ICD-10 Finland

Coma, unspecified

4.4

32.2

123

216

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.8

32.2

546

2325

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.1

32.1

403

1530

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

586

505

7.34

320.30

1.9

1.5

27045.0

32629.1

u/ml

0.09

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

22156

110235

1.43

317.99

2.7

2.1

75.2

898.2

nmol/l

0.50

20220

99823

(3015736) pH of Urine

20982

103564

1.43

313.13

4.1

3.1

5.8

5.7

0.09

(3052851) Hemolysis interference index of Serum or Plasma

2495

6673

2.40

311.77

4.1

2.8

—

(3010503) CD19 cells [#/volume] in Blood

803

1013

5.02

310.59

2.7

2.4

0.4

0.2

e9/l

0.63

782

987

(3035350) Ketones [Presence] in Urine by Test strip

26041

133733

1.41

310.09

4.5

3.2

0.0

estimate

2.09

5423

23916

(3018418) pH of Serum or Plasma

18935

72034

1.98

307.65

6.0

3.5

7.4

4.68

3892

13011

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

1148

1322

5.53

307.65

1.3

618.7

371.8

u/l

2.27

1094

1257

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

10272

23034

3.20

307.65

9.6

6.6

5.1

kpa

11.28

9728

22071

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2618

6220

2.72

307.65

4.5

2.6

50.4

40.4

mg/l

1.67

2093

5094

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

9504

24637

2.71

307.65

5.1

3.8

249.5

240.2

u/l

5.34

9078

23256

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

652

505

8.17

307.65

2.3

1.6

—

(3016502) Oxygen saturation in Arterial blood

9042

20743

3.06

307.65

10.1

6.9

94.6

96.3

93.99

8672

19985

(3018095) Leukocytes [#/volume] in Urine

21850

89873

1.86

307.65

4.8

3.2

88.5

96.3

e6/l

0.69

16562

60224

(3006504) Eosinophils/100 leukocytes in Blood

30525

120224

2.29

307.65

8.9

5.2

2.6

2.9

83.44

29091

111659

(3023419) Bacteria identified in Sputum by Culture

2116

1304

10.53

307.65

3.1

1.7

—

(3019060) Gas panel - Arterial blood

6355

12425

3.49

307.65

6.3

4.3

—

(36304419) Bacteria [Presence] in Urine

17599

66532

1.96

307.65

4.0

2.7

—

(44806118)

1845

1383

8.61

307.65

1.8

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

1149

1429

5.12

307.65

1.4

1.3

6.4

6.2

mmol/l

1.18

1054

1342

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

6580

17296

2.57

307.65

3.7

2.4

247.4

171.7

ng/l

23.56

6068

15659

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5862

18349

2.12

307.65

2.6

2.1

7.8

7.3

ug/l

0.77

5046

16059

(3033658) Prothrombin time (PT) actual/Normal

16350

64157

1.84

307.65

5.7

3.4

88.1

91.9

62.23

15947

62535

(3026493) Urate [Moles/volume] in Serum or Plasma

14937

66455

1.56

307.65

3.7

2.3

3362.2

4466.6

umol/l

3.05

13129

58037

(3023183) Ammonium ion [Moles/volume] in Plasma

2244

4076

3.55

307.65

2.8

2.7

33.0

34.1

umol/l

0.87

1926

3440

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2949

8024

2.37

307.65

3.1

1.9

3.8

g/l

0.58

2148

5714

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1589

1102

9.27

307.65

4.3

3.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

1328

1654

5.13

307.65

1.5

1.4

39442.0

51447.5

e6/l

0.85

813

956

(21494815) CD4 cells/100 lymphocytes in Specimen

1102

1589

4.41

307.65

2.2

2.1

36.8

43.3

3.32

115

229

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

3546

2214

10.64

307.65

1.4

1.1

—

(3047181) Lactate [Moles/volume] in Blood

2866

6600

2.81

307.65

8.4

4.6

1.3

mmol/l

2.82

2570

5772

(3032080) INR in Blood by Coagulation assay

25178

96397

2.15

307.65

11.5

7.3

1.3

1.2

inr

3.01

7388

27852

(3021901) Oxygen saturation in Capillary blood

2047

3248

4.06

307.65

3.7

2.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

2601

4433

3.81

307.65

4.7

2.8

8.1

8.7

kpa

34.20

2425

4132

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

5785

11446

3.42

307.65

1.7

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

10614

44987

1.59

307.65

3.6

2.8

2.5

2.4

mmol/l

70.80

9242

39321

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1414

690

13.14

307.65

1.2

1.1

—

(3026008) Bacteria identified in Urine by Culture

18943

73977

1.91

307.65

3.7

2.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

12577

18658

5.15

307.65

2.1

1.5

—

(3000991) Gas panel - Venous blood

7446

17920

2.85

307.65

11.2

7.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8044

27701

1.96

307.65

3.3

2.5

8.0

8.5

umol/l

1.04

6937

24024

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

5057

13496

2.48

307.65

12.7

8.1

1.4

1.3

9.75

5018

13415

(3002032) Base excess in Venous blood by calculation

8185

19322

2.94

307.65

5.5

3.4

2.2

1.7

mmol/l

22.23

6816

15647

(3014576) Chloride [Moles/volume] in Serum or Plasma

9569

27953

2.38

307.65

10.2

6.2

103.8

104.7

mmol/l

48.57

9289

27436

(3037522) Nuclear Ab [Titer] in Serum

8828

35297

1.67

307.65

1.4

1.3

551.1

539.5

titre

0.21

1957

6981

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6785

23981

1.88

307.65

4.6

2.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

6929

21764

2.13

307.65

2.5

2.1

362.7

382.6

nmol/l

10.20

6398

20080

(3027273) Bicarbonate [Moles/volume] in Venous blood

3836

10133

2.47

307.65

4.9

2.9

25.5

25.1

mmol/l

6.57

3710

9839

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

946

1292

4.65

307.65

2.6

2.4

775.6

686.0

e6/l

0.32

388

503

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

12630

18713

5.17

307.65

2.2

1.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

5062

13459

2.49

307.65

12.8

8.2

0.7

1.78

5025

13390

(3018572) Chloride [Moles/volume] in Blood

2033

4620

2.82

307.65

9.8

5.5

104.5

105.5

mmol/l

12.43

1832

4157

(3025159) Blasts/100 leukocytes in Blood

5641

18002

2.07

307.65

5.4

3.8

0.0

0.3

4.36

2058

3584

(40758558) Short blood count panel - Blood

16858

63691

1.94

307.65

10.2

5.9

—

(3018010) Neutrophils/100 leukocytes in Blood

30671

123558

2.22

307.65

8.7

5.1

59.7

56.3

307.65

29247

115381

(3039000) Anion gap in Blood

2033

4619

2.82

307.65

9.8

5.5

11.2

mmol/l

0.39

1832

4155

(3008152) Bicarbonate [Moles/volume] in Arterial blood

5392

12652

2.85

307.65

9.9

6.0

25.0

24.4

mmol/l

24.50

5053

11732

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1833

4049

2.90

307.65

1.3

1.2

184.0

98.9

titre

0.77

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

22609

89745

1.97

307.65

4.8

2.9

75.2

61.4

ng/l

0.46

16421

55759

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

3437

8689

2.57

307.65

7.3

4.1

1.8

1.6

9.28

3207

8154

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2880

7001

2.66

307.65

3.2

2.4

3.9

3.5

g/l

29.22

2771

6657

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3672

9892

2.42

307.65

4.1

2.6

1.4

1.2

9.98

3657

9839

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1604

1421

7.25

307.65

2.0

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

2433

4310

3.65

307.65

5.9

2.9

8.4

8.9

kpa

26.15

2380

4216

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1036

513

12.87

307.65

1.7

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1007

1233

5.19

307.65

2.0

2.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1221

1984

3.92

307.65

4.5

3.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

1628

2005

5.21

307.65

1.5

1.4

32.9

33.5

g/l

0.80

1467

1826

(1616796) Gas panel - Central venous blood

2561

4066

4.09

307.65

4.9

2.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3554

9738

2.37

307.65

4.1

2.6

0.7

0.20

3454

9301

(3035880) pH of Pleural fluid

726

734

6.26

307.65

1.2

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

646

495

8.26

307.65

2.3

1.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

2418

4284

3.65

307.65

5.8

2.9

5.1

5.0

kpa

5.28

2366

4190

(40767503) Oxygen content in Capillary blood by calculation

2230

4061

3.54

307.65

3.2

2.1

15.9

16.8

14.85

1197

2077

(4010399)

5027

16870

1.95

307.65

1.6

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2898

5940

3.17

307.65

1.9

1.6

—

(1175426) CD3 cells/100 lymphocytes in Blood

1053

1354

4.95

307.65

2.0

2.1

73.0

72.7

0.26

1006

1306

(3022948) Iron [Moles/volume] in Serum or Plasma

11384

37342

2.14

307.65

3.3

2.2

11.7

13.8

umol/l

163.23

10637

34559

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1367

994

8.81

307.65

1.9

1.4

—

(3020891) Body temperature

3091

8411

2.38

307.65

7.2

4.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

24331

122152

1.44

307.65

3.6

2.7

172.9

105.2

ug/l

69.36

22691

113792

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1035

505

13.06

307.65

1.7

1.2

—

(3023368) Bacteria identified in Blood by Culture

26650

51868

5.22

307.65

5.8

3.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2026

2805

4.66

307.65

3.8

2.3

5732.5

5680.8

u/ml

0.00

141

130

(3024139) IgG subclass 3 [Mass/volume] in Serum

1278

1872

4.35

307.65

1.4

1.3

0.4

g/l

1.02

932

1239

(3002173) Hemoglobin [Mass/volume] in Arterial blood

8023

19698

2.81

307.65

11.1

7.2

120.3

121.7

g/l

6.48

7733

18977

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

3755

2744

9.12

307.65

1.9

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

10186

31348

2.27

307.65

3.4

2.3

21.0

23.6

55.18

8703

26793

(3019198) Lymphocytes [#/volume] in Blood

32500

133284

2.25

307.65

8.6

5.1

1.9

e9/l

4.73

29168

116925

(3021589) Normoblasts [#/volume] in Blood

25500

118649

1.63

307.65

14.4

8.0

0.0

e9/l

0.86

20940

97031

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1367

994

8.81

307.65

1.9

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

6736

16582

2.76

307.65

3.7

2.2

10.2

10.8

g/l

18.01

6248

15096

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2481

1521

10.65

307.65

1.6

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2558

6017

2.74

307.65

4.4

2.6

7.1

2.7

ratio

0.91

198

478

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

3296

7077

3.04

307.65

2.8

2.1

634.5

510.9

ug/l

0.56

3097

6584

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1943

1151

10.92

307.65

1.9

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

14127

62929

1.54

307.65

3.1

2.1

—

(3023520) Reticulocytes [#/volume] in Blood

6309

18107

2.33

307.65

3.3

2.3

71.9

68.7

e9/l

7.57

4784

13520

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2958

8049

2.37

307.65

3.0

1.8

7.6

7.3

g/l

15.17

2223

6024

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

971

1218

5.06

307.65

2.5

2.4

581.2

483.1

e6/l

1.64

819

1006

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5329

17185

2.04

307.65

5.2

3.4

109.4

82.6

ng/l

41.81

4685

14833

(3028271) Lactate [Moles/volume] in Capillary blood

1716

2943

3.74

307.65

2.3

1.6

1.8

mmol/l

10.43

1682

2868

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1899

3781

3.22

307.65

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

10679

38898

1.89

307.65

3.5

2.6

3.2

3.0

e6/l

0.67

5923

20358

(44790049)

1845

1382

8.61

307.65

1.8

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

10948

28658

2.73

307.65

8.6

4.8

1.1

1.0

mmol/l

21.33

10332

26687

(3020779) Urea [Moles/volume] in Serum or Plasma

8072

18388

3.04

307.65

10.8

6.1

10.5

9.0

mmol/l

50.85

7747

17457

(3024891) Influenza virus A+B Ag [Presence] in Specimen

3071

4777

4.20

307.65

1.3

1.1

—

(3026782) Osmolality of Urine

13798

45912

2.17

307.65

3.4

2.4

526.4

553.5

mosm/kgh2o

28.49

12184

38445

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1995

4600

2.78

307.65

1.8

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

2385

1355

11.47

307.65

1.6

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

5048

10467

3.22

307.65

11.3

8.9

24.7

24.1

mmol/l

30.17

4656

9883

(3004809) Band form neutrophils/100 leukocytes in Blood

1791

3004

3.83

307.65

3.9

3.0

1.5

1.4

0.47

1430

2287

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

27962

110587

2.16

307.65

9.9

4.9

1.2

mmol/l

135.14

25991

99569

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

2869

3362

5.58

307.65

1.7

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

3545

2212

10.65

307.65

1.4

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

11050

42204

1.80

307.65

3.3

2.5

1.4

1.1

e6/l

0.61

6264

23478

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

811

623

8.26

307.65

2.2

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

903

1030

5.57

307.65

1.3

15.3

12.3

u/l

2.19

818

964

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

19909

78351

1.92

307.65

3.3

2.3

55.1

59.7

u/l

14.10

18648

71943

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

20165

86135

1.73

307.65

4.1

2.9

36.2

32.6

u/l

2.50

19208

81644

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3490

7347

3.11

307.65

2.3

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

645

495

8.25

307.65

2.3

1.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

1039

1334

4.95

307.65

2.0

2.1

13.4

14.4

0.99

509

630

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1600

1916

5.36

307.65

1.2

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1535

613

16.10

307.65

1.9

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

5963

17854

2.22

307.65

5.0

3.6

0.7

0.6

0.68

1903

3281

(3019069) Monocytes/100 leukocytes in Blood

30664

120877

2.30

307.65

9.3

5.4

8.6

8.5

4.42

29312

112928

(3021960) Folate [Moles/volume] in Serum or Plasma

13319

57201

1.60

307.65

1.7

1.5

19.4

20.7

nmol/l

18.58

11804

49020

(3013707) Erythrocyte sedimentation rate by Westergren method

37822

201492

1.54

307.65

5.5

3.6

16.1

10.6

mm/h

307.65

35535

186415

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3899

2761

9.43

307.65

1.9

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

9137

27489

2.29

307.65

2.1

1.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

35159

150788

2.23

307.65

14.0

7.7

4.6

3.9

e9/l

307.65

31526

130663

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2644

3728

4.61

307.65

7.5

4.5

2896.3

808.4

iu/ml

0.79

460

467

(3045788) Cell count panel - Pleural fluid

1133

1396

5.17

307.65

1.5

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1525

1247

7.85

307.65

2.0

1.4

—

(3012441) Differential panel - Pleural fluid

1255

1554

5.15

307.65

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2961

5076

3.80

307.65

1.4

1.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

31165

125309

2.25

307.65

9.0

5.2

25.3

29.2

307.65

29682

116412

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3369

9467

2.31

307.65

5.6

3.3

51.1

47.2

14.20

3333

9368

(40760888) Immunoglobulin light chains.free panel - Serum

2076

4495

2.97

307.65

4.6

2.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

6984

14489

3.31

307.65

1.9

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

812

621

8.30

307.65

2.2

1.5

—

(3012544) pH of Venous blood

8420

20175

2.90

307.65

5.4

3.4

7.4

0.12

(3027801) Oxygen [Partial pressure] in Arterial blood

10268

23023

3.20

307.65

9.5

6.6

11.0

13.5

kpa

307.65

9713

22052

(3014007) Fractional oxyhemoglobin in Arterial blood

5076

13534

2.48

307.65

12.9

8.3

92.9

94.5

52.47

5052

13497

(3042936) Bacteria identified in Isolate by Culture

11480

31567

2.61

307.65

2.5

1.8

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2955

8042

2.37

307.65

3.0

1.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

1470

1819

5.17

307.65

1.5

1.4

4464.7

2567.9

e6/l

1.33

1084

1288

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3517

8049

2.85

307.65

6.2

3.0

25.1

24.6

mmol/l

14.66

3320

7397

(3002582) Erythrocytes [#/volume] in Urine

19743

74139

2.03

307.65

4.2

2.8

67.8

87.8

e6/l

1.18

15850

55033

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2645

5807

2.95

307.65

1.6

1.4

19.5

11.7

iu/ml

1.59

114

(3011412) CD3 cells [#/volume] in Blood

1340

1665

5.14

307.65

2.4

2.3

1.1

1.2

e9/l

0.40

832

982

(4062490)

1284

1877

4.36

307.65

1.4

1.3

—

(3012501) Base excess in Blood by calculation

2417

4283

3.65

307.65

5.8

2.9

2.7

2.3

mmol/l

9.42

1806

2708

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1307

810

10.33

307.65

1.7

1.2

—

(44790047)

1845

1382

8.61

307.65

1.8

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

18484

82983

1.59

307.65

3.3

2.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2637

6954

2.44

307.65

1.9

1.6

0.2

g/l

2.17

2502

6601

(3006184) Hemoglobin [Mass/volume] in Capillary blood

2245

4773

3.03

307.65

2.6

1.9

127.2

131.9

g/l

11.64

1615

3510

(3003396) Base excess in Arterial blood by calculation

10256

23076

3.18

307.65

9.6

6.6

1.6

0.7

mmol/l

65.97

8277

17970

(40768806) Pleura Pathology biopsy report

1192

1604

4.74

307.65

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

11738

43345

1.88

307.65

1.9

1.7

1165.1

1165.4

nmol/l

0.01

9129

32653

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2684

7209

2.40

307.65

1.9

1.6

1.2

g/l

3.00

2551

6878

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2739

4618

3.86

307.65

4.2

2.4

25.1

24.3

mmol/l

14.06

2417

4061

(44790048)

1845

1383

8.61

307.65

1.8

1.3

—

(3013115) Eosinophils [#/volume] in Blood

32748

133607

2.29

307.65

9.1

5.3

0.2

e9/l

0.05

29327

116756

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

48953

281794

1.69

307.65

27.4

10.2

32.6

21.2

mg/l

307.65

44432

211775

(3001604) Monocytes [#/volume] in Blood

31899

128473

2.29

307.65

8.5

5.1

0.6

e9/l

238.35

28214

110597

(3004588) Protein electrophoresis panel - Serum or Plasma

5034

14281

2.33

307.65

3.1

2.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4764

11496

2.74

307.65

13.1

8.5

—

(42870588) Differential panel, method unspecified - Blood

24272

84090

2.42

307.65

8.3

5.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

13324

59459

1.53

307.65

6.4

3.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

16317

62166

1.91

307.65

2.6

2.1

3.1

2.8

mg/l

36.89

14243

52961

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

18270

62438

2.24

307.65

3.8

2.6

1954.3

1103.5

ng/l

66.63

16110

52530

(3027945) Reticulocytes/100 erythrocytes in Blood

8514

24620

2.38

307.65

3.3

2.3

1.9

1.7

34.52

7626

21747

(3021440) Promyelocytes/100 leukocytes in Blood

6126

18813

2.17

307.65

5.4

3.8

0.1

1.27

2435

4186

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2768

7515

2.38

307.65

3.0

1.9

10.2

g/l

0.31

2326

6272

(3015377) Calcium [Moles/volume] in Serum or Plasma

19240

85395

1.63

307.65

4.4

3.1

2.3

2.4

mmol/l

53.08

17085

74665

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

812

621

8.30

307.65

2.2

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1585

2378

4.27

307.65

7.4

5.6

11.7

11.3

mg/l

2.19

1445

2194

(3024354) Oxygen [Partial pressure] in Venous blood

6442

16198

2.68

307.65

4.6

2.8

4.8

4.6

kpa

6.36

6170

15737

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

13594

44035

2.23

307.65

4.9

3.1

433.4

553.1

ng/l

1.57

10772

31975

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1367

994

8.81

307.65

1.9

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

2620

6239

2.71

307.65

4.5

2.6

61.1

63.7

mg/l

0.08

2101

5105

(3022313) Gas panel - Capillary blood

4202

8957

3.10

307.65

5.7

2.9

—

(3006315) Basophils [#/volume] in Blood

32009

129113

2.29

307.65

8.5

5.1

0.0

e9/l

0.92

28329

111073

(3024980) IgG subclass 4 [Mass/volume] in Serum

1715

3284

3.34

307.65

1.5

1.6

0.7

0.8

g/l

1.24

1287

2453

(3020630) Protein [Mass/volume] in Serum or Plasma

6475

17294

2.52

307.65

3.2

2.2

65.0

67.1

g/l

73.07

5985

15703

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6951

21886

2.13

307.65

2.5

2.2

0.2

g/l

30.22

6408

20429

(3014111) Lactate [Moles/volume] in Serum or Plasma

7741

18471

2.89

307.65

9.2

6.4

1.4

1.3

mmol/l

4.49

7394

17918

(3022806) Fractional oxyhemoglobin in Capillary blood

1431

2346

3.90

307.65

2.2

1.5

89.2

90.3

7.57

1413

2309

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

5823

11801

3.33

307.65

5.3

2.8

2.1

1.4

mmol/l

34.67

4510

8339

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

15344

52931

2.12

307.65

2.3

1.6

1.4

1.2

mg/l

6.97

12326

39665

(3018405) Lactate [Moles/volume] in Arterial blood

2859

7109

2.60

307.65

5.8

3.7

1.4

mmol/l

0.13

2797

7001

(3024561) Albumin [Mass/volume] in Serum or Plasma

26644

107802

2.04

307.65

6.9

4.2

33.9

36.2

g/l

307.65

24979

99787

(3037756) Immunofixation for Serum or Plasma

1905

3903

3.13

307.65

1.9

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

4035

9399

2.82

307.65

1.9

1.7

1.6

1.5

g/l

23.81

3497

8019

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

6059

12416

3.31

307.65

5.3

2.8

5.2

5.1

kpa

13.17

5663

11413

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

4464

5142

5.82

307.65

3.1

2.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

4149

9016

3.03

307.65

1.7

1.4

12.6

14.0

u/ml

0.22

118

213

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

21802

104905

1.49

307.65

2.2

1.9

93.0

97.1

pmol/l

30.14

12159

54284

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

5604

11190

3.37

307.65

2.0

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

3356

8570

2.55

307.65

7.5

4.1

0.9

0.25

3139

8034

(3012095) Magnesium [Moles/volume] in Serum or Plasma

13138

36208

2.66

307.65

4.8

2.9

0.8

mmol/l

31.98

12383

33742

(3000850) Epithelial cells [#/volume] in Urine

14377

49864

2.08

307.65

3.3

2.3

6.2

5.7

e6/l

4.05

12923

42972

(3017181) Myelocytes/100 leukocytes in Blood

6643

19565

2.28

307.65

5.2

3.8

1.0

0.9

0.26

2638

4509

(3028026) IgM [Mass/volume] in Serum or Plasma

5331

12678

2.81

307.65

2.2

1.7

1.2

1.3

g/l

2.48

4856

11590

(3013826) Glucose [Moles/volume] in Serum or Plasma

34192

149653

2.10

307.65

7.7

3.9

6.9

6.6

mmol/l

88.84

32624

137376

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

707

574

7.80

307.65

4.6

3.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

2584

1747

9.67

307.65

1.6

1.2

—

(3042631) Mycobacterium sp identified in Specimen

1725

2058

5.39

307.65

3.3

2.0

—

(3022096) Basophils/100 leukocytes in Blood

29884

116080

2.31

307.65

8.9

5.3

0.6

0.7

138.25

28496

107843

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

30115

123229

2.15

307.65

10.9

5.4

1.2

mmol/l

101.93

25841

103613

(3027135) IgG subclass 1 [Mass/volume] in Serum

1279

1876

4.35

307.65

1.4

1.3

6.7

7.0

g/l

1.20

929

1234

(3030467) Casts [#/volume] in Urine by Automated count

18085

67943

1.98

307.65

4.0

2.8

0.5

0.4

e6/l

10.19

14227

49487

(3004119) Hemoglobin [Mass/volume] in Venous blood

4671

13047

2.36

307.65

4.8

2.9

124.9

130.7

g/l

48.32

4546

12771

(3037467) Urinalysis macro (dipstick) panel - Urine

36750

187698

1.66

307.65

5.7

3.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

36553

176651

1.85

307.65

5.8

3.8

1243.7

1522.8

e6/l

0.45

637

2245

(3028192) IgG subclass 2 [Mass/volume] in Serum

1279

1873

4.35

307.65

1.4

1.3

2.7

3.1

g/l

10.69

931

1235

(3022217) INR in Platelet poor plasma by Coagulation assay

8553

28781

2.02

307.65

26.5

22.2

1.4

1.3

inr

5.12

1191

4205

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

17214

28396

5.03

307.65

2.3

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

8186

19424

2.92

307.65

5.4

3.4

5.9

5.8

kpa

14.03

7902

18928

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

2379

1377

11.26

307.65

1.8

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

5487

13097

2.80

307.65

9.0

6.7

25.1

24.6

mmol/l

17.92

5430

12999

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3898

7962

3.22

307.65

2.6

1.6

—

(3000494) Fungus identified in Specimen by Culture

8220

28406

1.95

307.65

1.8

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

4984

6139

5.48

307.65

2.3

1.8

2.3

2.4

ug/l

0.15

4490

5356

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

812

621

8.30

307.65

2.2

1.5

—

(3009343) pH of Capillary blood

5989

12250

3.31

307.65

5.3

2.8

7.4

0.49

892

1491

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

3138

7188

2.84

307.65

1.7

1.5

355.4

256.0

titre

0.88

136

279

(3018677) aPTT in Platelet poor plasma by Coagulation assay

10859

35880

2.11

307.65

2.8

1.9

30.3

29.6

17.39

10551

34841

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

4683

9909

3.14

307.65

5.7

3.8

24.4

24.0

mmol/l

11.68

4280

8894

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1147

589

12.43

307.65

1.7

1.2

—

(3010421) pH of Blood

2679

5057

3.44

307.65

5.8

2.8

7.4

1.86

2369

4191

(3004789) Transferrin [Mass/volume] in Serum or Plasma

10716

34102

2.20

307.65

3.3

2.2

2.3

2.4

g/l

78.07

10005

31428

(3005322) IgE [Units/volume] in Serum or Plasma

4753

15369

2.02

307.65

1.5

1.2

266.1

224.6

u/ml

1.54

4392

14197

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3062

2032

9.93

307.65

1.6

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

789

283

17.70

307.65

1.6

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

32027

130227

2.26

307.65

8.7

5.3

10.8

11.5

umol/l

16.04

30671

122845

(3009466) Valproate [Moles/volume] in Serum or Plasma

1585

3140

3.23

307.65

6.0

4.8

374.2

371.3

umol/l

0.28

1392

2735

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

3551

6072

3.84

307.65

3.7

2.9

0.3

0.4

u/ml

7.57

2122

3293

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

938

1181

5.04

307.65

2.5

2.4

0.2

e9/l

0.72

819

1008

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

935

1067

5.57

307.65

1.5

1.4

12.8

12.2

u/l

1.33

899

1041

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2781

7595

2.36

307.65

3.1

1.9

3.2

3.0

g/l

26.24

2177

5898

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

18146

73353

1.81

307.65

2.7

1.9

259.2

200.9

u/l

5.78

17159

68717

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

6656

22632

1.96

307.65

3.0

2.3

51.8

44.8

u/l

0.25

5700

19393

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

2941

1834

10.55

307.65

2.0

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

40907

204826

1.93

307.65

11.5

6.4

82.7

76.7

u/l

93.04

39327

192137

(3024928) Oxygen saturation in Venous blood

1878

4407

2.73

304.66

4.2

3.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

925

1350

4.35

303.89

19.4

18.8

2307.5

3198.8

nmol/l

0.25

884

1292

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1541

3237

3.04

303.60

1.6

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

25124

128534

1.41

303.13

5.3

3.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2514

6838

2.36

302.69

3.2

2.0

1.0

0.8

g/l

1.31

2180

5884

(3043409) Potassium [Moles/volume] in Arterial blood

2353

6248

2.42

298.37

6.4

3.9

mmol/l

0.42

2160

5927

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1551

3321

2.98

295.87

3.3

3.0

0.8

nmol/l

2.70

1196

2553

(3009261) Glucose [Presence] in Urine by Test strip

26244

135692

1.40

294.45

4.6

3.3

0.0

estimate

0.30

5362

23959

(3010375) cycloSPORINE [Mass/volume] in Blood

640

691

5.86

288.75

33.7

24.3

116.5

119.7

ug/l

0.36

526

582

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2697

7743

2.24

286.91

3.0

2.1

91.1

92.4

1.84

2581

7130

(3021601) Nitrite [Presence] in Urine by Test strip

25943

134237

1.39

286.81

6.1

4.4

0.0

estimate

1.73

5569

24507

(3007164) IgA [Mass/volume] in Serum or Plasma

11755

52578

1.51

285.42

1.8

1.4

2.5

2.3

g/l

8.99

7613

31539

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

874

1285

4.31

284.58

13.7

13.6

834.0

1581.3

nmol/l

0.48

847

1242

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

475

362

8.28

284.37

1.2

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2243

6063

2.37

273.28

2.9

1.9

0.0

g/l

1.19

2060

5541

(3026250) Tacrolimus [Mass/volume] in Blood

636

724

5.56

272.88

39.7

34.8

7.4

ug/l

0.12

578

661

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1914

4813

2.54

271.30

1.6

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1897

4778

2.54

267.97

1.6

1.4

20.8

18.7

u/ml

0.24

(3008536) Aspergillus sp Ab [Presence] in Serum

377

224

10.61

264.72

2.2

—

(40757373) Influenza virus identified in Isolate

357

193

11.66

264.24

1.8

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2277

6298

2.32

263.48

2.8

1.9

36.3

38.4

g/l

41.31

1998

5374

(3003181) Sodium [Moles/volume] in Urine

1532

3480

2.81

263.38

1.6

1.4

62.2

63.9

mmol/l

0.69

1189

2756

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2235

6159

2.33

260.74

5.0

3.3

1.7

1.4

mg/l

49.07

2071

5668

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2090

5596

2.39

259.76

2.9

1.9

0.0

g/l

0.09

1910

5096

(3000492) Spirometry study

6245

24558

1.67

259.76

1.7

1.4

—

(3036489) Thrombin time

2976

9258

2.07

258.76

2.7

1.9

21.7

21.4

1.83

2668

7964

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

2055

5525

2.38

253.04

2.9

1.9

0.0

g/l

0.00

1903

5083

(3017354) Segmented neutrophils/100 leukocytes in Blood

1033

1887

3.48

252.53

3.9

3.0

60.3

57.0

3.31

697

1202

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2435

7080

2.21

250.67

3.1

2.4

203.0

180.9

23.62

2338

6695

(3017143) Hepatitis C virus Ab [Presence] in Serum

7909

33256

1.57

250.13

1.9

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2595

7767

2.15

248.83

1.4

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

735

1048

4.44

248.12

2.7

37.9

40.9

1.87

273

340

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1844

4764

2.47

247.06

1.4

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

833

1341

3.94

242.18

1.6

1.1

1.6

0.7

u/ml

1.91

498

438

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5137

19538

1.71

240.54

5.9

3.2

1.2

mmol/l

21.40

4697

16780

(3030905) Polymorphonuclear cells [#/volume] in Blood

1764

4539

2.48

238.23

4.0

3.1

4.6

3.9

e9/l

21.27

1759

4531

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

6149

24659

1.63

235.40

3.9

4.0

21.4

25.9

ug/l

0.52

5067

19484

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1743

4492

2.48

234.59

1.4

1.2

292.5

251.5

u/ml

5.86

1104

2883

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1737

4470

2.48

234.49

1.6

1.4

116.2

109.0

u/ml

0.74

337

1040

(3009508) Creatinine [Moles/volume] in Urine

16490

81054

1.39

232.82

3.8

3.1

7.3

8.0

mmol/l

3.36

14026

68553

(3006245) CD3-CD19+ cells/100 cells in Blood

567

692

5.18

226.95

2.0

2.3

10.6

10.1

0.26

521

646

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2145

6172

2.22

225.99

2.1

2.0

11.7

10.5

mg/l

4.34

2013

5791

(3028433) Virus identified in Specimen by Culture

490

527

5.87

221.89

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3036

10081

1.94

219.59

2.1

1.9

38.6

40.0

u/l

2.85

2696

9019

(3020682) Albumin/Creatinine [Ratio] in Urine

15719

77229

1.38

219.59

4.6

3.9

15.9

7.8

mg/mmol

36.53

10558

48233

(3019550) Sodium [Moles/volume] in Serum or Plasma

48610

285013

1.51

218.98

29.2

12.1

139.2

139.7

mmol/l

307.65

47747

277103

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1374

3255

2.69

218.32

1.8

1.5

—

(3012516) Albumin [Mass/volume] in Urine

15022

73375

1.39

216.77

3.8

3.2

630.2

368.0

mg/l

7.01

10259

45425

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

549

685

5.06

214.78

1.9

2.1

30.2

28.5

1.38

514

653

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2122

6221

2.18

213.56

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

48693

285890

1.50

213.23

29.4

12.2

4.0

mmol/l

29.49

47745

277389

(3019977) pH of Arterial blood

654

965

4.28

211.98

2.9

2.3

7.4

0.70

216

330

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

695

1104

3.98

205.55

1.6

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2225

6770

2.10

203.91

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1404

3492

2.56

202.88

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

683

1087

3.97

201.51

1.6

1.2

—

(3013512) EKG study

14585

71596

1.37

200.96

4.7

3.5

—

(4035726)

5426

21935

1.61

198.90

1.5

1.4

—

(4015189)

378

346

6.88

196.98

3.0

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

12055

57551

1.40

195.43

2.0

1.9

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

1086

2419

2.85

193.02

2.0

1.9

22.5

24.7

ug/l

0.60

1061

2370

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2377

7620

2.00

189.32

1.6

3.0

4.9

iu/ml

0.25

563

1495

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1712

4832

2.26

188.30

1.6

1.3

—

(3042733) HLA Ab [Presence] in Serum

481

601

5.05

187.93

5.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

11272

53540

1.40

186.92

1.8

1.6

30108657.7

36209373.5

pmol/l

0.52

9426

44663

(3016228) CD19 cells/100 cells in Blood

513

697

4.64

183.04

2.1

2.0

8.7

8.4

0.15

501

680

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

276

181

9.60

182.68

2.5

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

896

1852

3.06

180.87

3.5

2.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

397

426

5.87

180.21

1.3

3.3

3.5

mmol/l

0.42

361

398

(3011397) Hemoglobin [Presence] in Urine by Test strip

12842

62673

1.37

179.56

4.2

3.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

501

684

4.62

177.79

2.1

2.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

560

848

4.17

175.90

3.9

2.9

—

(3000060) B lymphocytes [#/volume] in Blood

422

503

5.29

173.08

1.8

2.2

426.0

838.7

e6/l

0.36

246

253

(3044889) 12 lead EKG panel

33465

187458

1.29

170.12

4.5

3.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5143

21266

1.57

169.83

1.5

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

424

523

5.11

167.93

2.1

1.9

—

(3017569) Oxygen content in Arterial blood

516

773

4.21

164.25

2.1

—

(40768797) Stomach Pathology biopsy report

7686

34829

1.44

162.99

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

3811

14797

1.66

162.26

1.4

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

416

526

4.98

160.56

1.4

55.3

66.3

5.91

336

436

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

528

821

4.06

160.50

1.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

527

821

4.05

159.81

1.6

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

345

365

5.95

158.70

1.2

1.3

94.7

91.6

0.82

340

357

(3037121) Protein [Mass/volume] in Urine

2401

8215

1.87

157.60

3.9

3.0

0.4

0.3

g/l

2.68

1255

3411

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

33513

188712

1.28

156.10

4.0

2.8

59.2

43.3

u/l

123.29

31547

176985

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

341

363

5.92

155.98

1.2

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

165

18.85

151.39

1.8

1.5

46.8

44.9

umol/l

0.17

165

(3029937) Albumin [Presence] in Urine by Test strip

14135

71452

1.32

151.36

5.2

3.6

0.0

estimate

1.49

5185

23773

(3040151) Glucose [Moles/volume] in Capillary blood

998

2424

2.61

150.94

16.8

4.6

7.5

7.2

mmol/l

0.98

846

1937

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

819

1787

2.90

150.87

1.2

249.0

132.5

titre

0.72

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

820

1794

2.89

150.35

1.2

165.6

189.4

titre

0.35

136

305

(3001964) Herpes simplex virus Ag [Presence] in Specimen

408

542

4.74

149.33

2.0

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3298

12608

1.68

148.46

3.5

2.5

0.3

e6/l

1.70

3221

12229

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

402

530

4.78

148.36

3.3

2.8

—

(3019230) Fractional oxyhemoglobin in Venous blood

1343

3788

2.25

147.67

4.4

2.9

64.7

65.0

0.19

1335

3775

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

538

905

3.75

147.61

1.3

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1237

3377

2.32

146.55

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

198

108

11.52

145.95

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

506

824

3.87

144.97

2.3

1.9

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

178

13.98

144.55

1.5

1.9

2.1

mg/l

0.09

115

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

595

1096

3.43

143.66

2.6

2.4

1231.0

934.4

u/ml

1.59

590

1086

(3045142) Bone marrow Pathology biopsy report

927

2225

2.64

143.45

1.5

1.3

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

175

13.92

141.82

1.5

2.6

2.7

mg/l

0.02

118

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

175

13.92

141.82

1.5

1.9

1.2

mg/l

0.92

125

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

175

13.92

141.82

1.5

3.7

3.9

mg/l

0.09

115

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

175

13.92

141.82

1.5

2.4

2.0

mg/l

0.18

115

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

175

13.92

141.82

1.5

1.2

0.6

mg/l

0.99

111

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

175

13.92

141.82

1.5

1.3

0.6

mg/l

1.53

116

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

175

13.92

141.82

1.5

1.6

1.9

mg/l

0.24

106

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

175

13.92

141.82

1.5

2.3

2.0

mg/l

0.15

129

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

175

13.92

141.82

1.5

3.0

3.2

mg/l

0.07

121

(3051651) Icteric interference index of Serum or Plasma

631

1220

3.27

141.65

4.9

3.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2018

6754

1.90

141.35

1.4

261.7

279.5

ug/g

3.03

1188

3878

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

311

336

5.83

140.37

1.4

26.4

19.3

2.96

252

293

(3024471) HLA-A [Type]

436

649

4.23

139.93

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

1088

2874

2.40

138.54

1.6

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

177

12.93

138.50

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

3395

32648

0.63

137.99

1.3

—

(3024932) HLA-DR beta [Type]

427

636

4.23

136.94

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1212

3406

2.26

134.35

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

132

25.12

132.76

1.1

1.0

—

(1761868) Lipid panel - Serum or Plasma

13993

105481

0.78

131.67

2.9

2.6

—

(3008295) Osmolality of Serum or Plasma

873

2129

2.59

130.98

1.4

1.6

278.9

280.5

mosm/kgh2o

0.91

669

1653

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

963

2467

2.47

130.82

1.3

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

19458

103979

1.26

130.78

4.9

3.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

849

2044

2.63

130.61

2.7

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

33628

191300

1.25

130.41

3.4

3.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

705

1536

2.90

130.22

2.4

1.6

4.6

3.4

mg/l

7.02

671

1473

(3013727) Leukocytes other/100 leukocytes in Blood

394

579

4.29

128.46

4.2

3.0

54.9

51.6

1.73

384

557

(3017704) Immunofixation for Urine

536

998

3.39

127.41

2.0

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1245

3644

2.17

125.19

1.3

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1041

2850

2.31

122.48

1.7

1.3

—

(40768446) Kidney Pathology biopsy report

460

793

3.66

122.12

1.8

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

176

108

10.24

121.41

1.2

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

7348

34648

1.38

120.68

2.0

1.7

1.6

1.4

55.95

6395

30928

(3035947) Staphylolysin Ab [Units/volume] in Serum

526

1004

3.30

120.48

1.2

1.1

4.3

3.9

iu/ml

0.22

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1018

2782

2.32

120.26

1.7

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

505

942

3.38

119.74

2.1

127.8

136.2

umol/l

0.20

244

495

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1009

2757

2.32

119.24

1.7

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

786

1907

2.60

119.13

2.7

2.4

0.2

0.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1007

2755

2.31

118.67

1.7

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1006

2752

2.31

118.57

1.7

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

743

1757

2.67

118.31

2.1

1.9

1.3

0.8

g/24h

0.71

100

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

255

268

5.98

118.13

1.2

1.4

407.5

61.5

ng/l

0.63

185

144

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1011

2777

2.30

118.07

1.7

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

154

12.40

118.06

1.2

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

400

644

3.91

116.41

7.2

5.6

25.0

25.1

mmol/l

0.16

356

587

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

230

219

6.60

116.16

1.7

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

829

2104

2.49

114.81

1.6

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

312

414

4.74

114.45

1.3

151.0

442.7

ug/l

1.54

174

208

(3001893) Eosinophils/100 leukocytes in Pleural fluid

333

469

4.47

114.20

1.3

1.4

2.9

2.7

0.12

280

395

(3019225) pH of Specimen

5369

24243

1.43

112.73

6.6

3.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

773

1921

2.54

111.74

1.7

1.4

promille

0.22

596

1496

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

862

2262

2.41

111.32

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

1947

6970

1.78

109.90

1.2

109.8

133.6

titre

0.72

192

598

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3098

29019

0.65

109.56

1.7

—

(3034770) Mitochondria Ab [Titer] in Serum

1920

6861

1.78

109.02

1.2

812.3

950.9

titre

0.38

206

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

354

547

4.07

108.60

3.4

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

354

547

4.07

108.60

3.4

2.1

—

(3017732) Neutrophils [#/volume] in Blood

4162

18031

1.48

108.21

3.8

2.5

4.6

4.0

e9/l

29.38

3222

14161

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1770

6186

1.82

108.09

1.5

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

140

12.56

108.05

1.1

—

(40761536) Microorganisms panel - Urine sediment

5003

22520

1.43

106.49

5.3

3.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

431

784

3.46

106.10

2.8

2.9

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

416

739

3.55

105.96

2.5

1.9

60.6

62.5

ug/l

0.17

410

719

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

950

2664

2.26

105.80

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

483

951

3.20

105.51

1.8

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

141

11.81

105.41

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

483

952

3.20

105.33

1.8

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1301

4157

1.98

103.91

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

805

2119

2.40

103.28

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

13944

73173

1.26

103.18

4.3

2.9

—

(3021788) Differential panel - Synovial fluid

1304

4185

1.97

102.86

1.6

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1281

4087

1.99

102.73

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2569

10134

1.62

101.36

1.3

1.2

1.0

0.9

u/ml

0.26

206

871

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

233

263

5.57

101.02

1.4

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

891

2481

2.27

100.87

1.3

1.2

62.3

66.0

u/l

0.45

669

1620

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

987

2875

2.17

100.39

2.4

2.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

14363

75848

1.25

99.94

4.4

4.9

3.4

3.3

ug/l

0.13

12805

68339

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2087

7828

1.70

99.93

2.1

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

254

319

5.01

98.92

1.5

1.2

—

(40761535) Cells panel - Urine sediment

4538

20340

1.43

98.45

4.4

3.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

6343

51526

0.74

98.35

1.5

1.4

—

(3045716) Anion gap in Serum or Plasma

447

879

3.20

97.87

2.7

2.2

8.8

9.5

mmol/l

2.83

329

636

(3044927) Protein electrophoresis panel - Urine

752

1968

2.41

97.70

1.2

—

(3019150) Specific gravity of Urine by Refractometry

11405

58756

1.27

97.53

5.0

3.6

1.0

kg/l

0.57

1770

8509

(21494434) Karyotype in Bone marrow

695

1755

2.50

97.30

1.2

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

296

433

4.30

97.16

1.3

1.4

27.7

18.0

5.55

270

388

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

628

1511

2.62

96.80

1.3

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

244

303

5.06

96.17

5.7

5.9

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

236

287

5.17

95.05

3.4

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1112

3472

2.03

94.61

1.3

63.0

28.2

u/l

6.61

974

3034

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1711

6170

1.76

94.08

1.4

1.3

587.2

516.6

mg/l

1.65

1617

5904

(3000475) Leukocytes [#/volume] in Synovial fluid

1595

5633

1.80

94.04

1.7

1.6

16756.7

12050.3

e6/l

2.26

1179

4061

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2297

9057

1.61

90.61

1.4

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

1970

7470

1.68

90.48

1.3

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

840

2391

2.22

90.34

4.7

2.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1964

7450

1.68

90.08

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1949

7384

1.68

89.80

1.3

1.1

—

(3014891) Appearance of Pleural fluid

178

170

6.58

89.77

1.7

1.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

446

926

3.03

89.52

2.1

1.7

2.0

umol/l

0.06

421

863

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

123

11.03

88.68

1.9

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1163

3786

1.94

88.07

1.1

12.5

12.0

au/ml

0.05

276

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

931

2795

2.11

87.82

2.7

2.0

32.0

32.8

5.28

922

2776

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

144

109

8.30

86.85

3.9

3.4

2.2

mg/l

0.01

126

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

9416

48048

1.27

85.40

1.8

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2016

19671

0.63

84.99

1.4

—

(3016038) Potassium [Moles/volume] in Urine

565

1377

2.59

84.99

1.4

1.2

31.8

34.9

mmol/l

2.41

486

1207

(44786800) Granulocytes/100 leukocytes in Body fluid

166

156

6.68

84.88

1.3

30.7

17.1

3.80

130

117

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1284

4395

1.85

83.64

4.8

2.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1844

18284

0.62

83.38

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

1441

5124

1.78

83.01

1.6

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1507

5437

1.76

82.66

1.4

1.3

3.9

3.7

mmol/l

6.30

1395

5135

(3008037) Lactate [Moles/volume] in Venous blood

1396

4925

1.80

82.54

4.6

2.6

1.6

mmol/l

0.18

1366

4830

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

359

687

3.29

82.07

1.4

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2137

8485

1.60

81.81

3.4

3.5

933.2

2316.9

u/ml

0.93

1823

7260

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

556

1371

2.56

81.74

1.3

1.2

109.8

81.6

u/l

5.73

503

1188

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

171

175

6.14

81.28

1.3

113.6

215.8

u/l

0.27

120

134

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1507

5468

1.75

81.05

1.6

1.4

1435.5

2417.9

e6/l

0.53

1247

4386

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1164

3902

1.89

80.84

1.3

1.2

4.4

3.9

u/ml

0.70

550

1716

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1503

5466

1.74

80.19

1.6

1.4

40.1

26.3

e6/l

0.90

1183

4180

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

540

1332

2.55

79.35

1.3

1.2

35.0

19.4

u/l

5.95

484

1134

(3041354) Potassium [Moles/volume] in Venous blood

862

2622

2.08

78.63

3.2

2.0

4.1

4.0

mmol/l

0.23

854

2602

(3044941) Cell count panel - Synovial fluid

1085

3587

1.91

78.55

1.5

1.4

—

(3035285) Chloride [Moles/volume] in Venous blood

861

2622

2.07

78.30

3.2

2.0

105.1

105.9

mmol/l

3.99

853

2601

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1014

3282

1.95

78.07

1.1

1.6

1.5

g/l

7.01

935

2962

(3004451) EKG impression Narrative

421

918

2.89

77.84

1.4

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

432

959

2.84

77.40

6.3

3.6

1656.3

2281.6

mg/l

0.26

339

648

(4198724)

504

1216

2.61

77.37

2.4

2.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

9055

46512

1.26

76.69

1.3

41.1

34.9

iu/ml

1.77

2869

14546

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

181

211

5.39

76.17

1.5

1.3

63.5

88.7

u/ml

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

695

1972

2.22

75.37

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

212

291

4.58

75.06

1.3

1.2

1.7

1.8

mmol/l

0.42

145

159

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

287

503

3.59

74.67

2.0

1.8

46.7

34.1

u/l

0.56

263

443

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1173

4052

1.83

74.23

1.4

1.2

4.8

3.3

u/ml

1.11

410

1398

(3033705) Calcium.ionized [Moles/volume] in Venous blood

839

2587

2.05

73.86

3.2

2.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

157

164

6.01

73.31

1.4

1.3

65.5

76.5

2.86

128

144

(3047189) Immunofixation for 24 hour Urine

391

853

2.88

72.27

2.2

1.6

—

(3014271) Vancomycin [Susceptibility]

415

943

2.77

71.35

3.3

2.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

271

476

3.58

70.33

1.2

1.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

564

1510

2.35

69.87

13.2

11.3

0.6

mmol/l

1.89

516

1393

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1406

5227

1.70

69.34

1.2

11.1

16.9

u/ml

0.37

(3038515) Glucose [Moles/volume] in Venous blood

1283

4666

1.74

68.42

4.9

2.6

7.8

7.5

mmol/l

2.22

1260

4585

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

154

170

5.69

68.36

3.7

2.5

1.1

1.4

mg/l

0.59

107

116

(3002385) Erythrocyte distribution width [Ratio]

40314

239569

1.19

67.93

30.4

13.1

14.0

13.5

307.65

39696

234222

(40762365) Oxygen content in Arterial blood by calculation

197

278

4.45

67.63

3.0

3.2

14.9

14.7

ml/dl

0.47

185

261

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

533

1414

2.37

67.39

2.4

2.0

97.9

98.8

0.20

515

1317

(3032057) Clostridioides difficile [Presence] in Stool

221

348

3.99

66.42

1.9

1.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

846

2721

1.96

66.36

1.9

1.5

38.7

31.2

iu/ml

0.50

121

(3042010) Triglyceride [Moles/volume] in Pleural fluid

176

231

4.79

65.56

1.3

1.2

0.7

2.0

mmol/l

2.22

114

145

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

437

1074

2.56

64.79

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

620

1796

2.18

64.04

1.3

1.2

2.3

2.0

mmol/l

4.45

572

1670

(3028707) Methadone [Presence] in Urine by Screen method

1369

5168

1.68

63.81

4.2

2.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

531

1445

2.31

63.50

1.7

1.5

6.8

6.2

u/l

0.23

309

668

(3029634) Reagin Ab [Titer] in Serum by VDRL

1056

3729

1.79

62.25

2.3

2.0

7.7

8.0

titre

0.02

108

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

551

1540

2.25

62.00

2.2

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

8410

43796

1.24

61.47

1.3

16.8

10.7

u/ml

4.54

2931

17508

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3682

17246

1.36

60.40

3.2

3.4

4.4

4.5

pmol/l

16.20

3239

15433

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

170

233

4.58

60.40

1.4

12.8

11.1

0.32

118

(3050129) First trimester maternal screen panel - Serum or Plasma

1196

12171

0.61

59.90

1.5

1.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

841

2807

1.89

59.24

1.2

1.1

2.5

2.1

iu/ml

0.28

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4315

20763

1.33

59.14

3.4

2.4

61.3

69.0

ml/min/173m2

21.85

1895

7938

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1060

3811

1.76

58.83

1.2

1.1

117.0

118.3

0.52

988

3430

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

863

2914

1.87

58.69

1.7

1.5

60.7

55.1

3.54

558

1829

(4306422)

1087

3940

1.74

58.66

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

6697

34209

1.26

57.78

2.5

2.3

163.4

126.9

ug/g

8.10

5404

26735

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1032

3707

1.76

57.46

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1845

16933

0.67

57.11

1.7

1.6

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

357

848

2.65

56.64

2.6

2.3

149.7

153.6

nmol/l

0.24

312

731

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1366

5327

1.62

56.14

1.3

1.2

4.7

6.2

u/ml

0.34

111

392

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

824

2783

1.87

56.02

1.2

1.1

93.2

95.9

1.85

785

2603

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

464

1259

2.32

55.92

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

688

2197

1.97

55.15

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

455

1232

2.32

55.10

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

482

1340

2.26

54.98

1.3

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1628

6656

1.55

54.80

1.3

7.8

9.5

u/ml

0.56

283

1018

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

567

1692

2.11

54.48

1.4

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1741

7242

1.52

54.19

1.3

37.8

34.1

u/ml

0.25

118

431

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1604

6562

1.55

53.84

1.3

7.3

6.8

u/ml

0.09

185

667

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

418

1101

2.39

53.80

1.8

1.5

2241092.9

1355424.5

iu/ml

0.52

(3026389) Candida sp identified in Specimen by Organism specific culture

1014

3730

1.72

51.99

1.4

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

248

504

3.09

51.81

11.0

7.2

—

(3048879) Bone marrow aspiration report

262

553

2.98

51.43

2.2

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

43658

263017

1.18

51.42

22.5

10.2

82.3

84.0

ml/min/173m2

35.13

37475

212385

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

197

346

3.58

51.29

2.6

2.3

69.4

40.6

mg/l

0.88

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

232

465

3.13

49.59

1.4

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

355

900

2.48

49.57

2.5

2.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

100

6.40

49.52

2.4

2.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1222

4795

1.61

49.00

3.4

3.3

557.1

987.5

u/ml

1.09

1102

4350

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

36738

218725

1.15

48.71

4.3

3.9

14.8

14.7

pmol/l

12.48

33729

199534

(3022621) pH of Urine by Test strip

3513

16862

1.33

48.63

3.4

2.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1085

10766

0.62

48.62

1.4

1.5

—

(3022145) Colonoscopy Study observation

5779

29562

1.25

48.60

1.4

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

49362

301079

1.22

48.08

28.3

12.5

81.2

74.8

umol/l

165.10

49345

300921

(4268621)

774

2694

1.81

47.92

2.5

2.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

460

1330

2.18

47.88

1.6

1.4

6.1

6.0

u/l

0.09

378

1113

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1047

3980

1.66

47.58

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1258

5013

1.59

47.33

1.4

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

436

1241

2.21

47.14

1.7

1.6

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

112

134

5.24

46.11

1.1

10.6

8.0

mg/l

1.20

106

122

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

782

8290

0.59

46.09

1.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1495

6235

1.52

45.96

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

876

9009

0.60

45.71

1.5

1.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

171

295

3.64

45.71

5.5

4.5

50.7

47.7

ug/min

0.21

141

223

(3014148) Varicella zoster virus Ab [Titer] in Serum

956

3590

1.68

45.50

1.1

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

123

164

4.71

45.19

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

100

6.02

45.10

1.1

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

349

919

2.39

45.05

1.1

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.74

45.01

5.6

5.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

235

505

2.92

44.82

1.1

1.2

180.0

637.3

titre

0.72

(3049717) Cytology report of Urine Cyto stain

1992

8844

1.43

44.60

2.5

2.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

321

817

2.47

44.53

2.9

29.0

28.4

umol/l

0.38

226

642

(40763480) Human metapneumovirus Ag [Presence] in Specimen

8.73

44.51

1.8

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

147

231

3.99

44.48

4.2

2.6

38.1

43.4

umol/l

1.77

127

197

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1410

5867

1.52

43.82

2.7

2.3

136.6

101.2

ug/min

1.91

872

3465

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

11045

60686

1.17

43.67

3.9

4.3

21.8

22.0

0.63

4894

29341

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

510

1593

2.01

43.58

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

966

9597

0.62

43.49

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

969

9616

0.62

43.41

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

970

9623

0.63

43.40

1.4

—

(3012565) Volume of 24 hour Urine

409

1177

2.19

43.13

2.4

2.1

1859.7

2012.4

1.67

364

1056

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

965

9568

0.63

43.07

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

9873

53804

1.18

43.00

1.7

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

510

1603

2.00

42.85

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

356

973

2.30

42.36

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

195

388

3.16

42.26

1.4

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

195

389

3.15

42.09

1.4

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

543

1758

1.94

41.99

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

412

1203

2.15

41.95

2.4

2.1

38.3

32.8

umol/l

0.20

102

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

592

1975

1.89

41.91

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

588

1958

1.89

41.86

1.2

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3870

19195

1.28

41.80

2.4

2.1

11.9

12.3

nmol/l

2.16

3375

17077

(3002523) Influenza virus A Ag [Presence] in Specimen

1058

4168

1.60

41.78

1.2

1.1

—

(40768804) Tissue Pathology biopsy report

19514

112055

1.14

41.65

2.2

2.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

587

1957

1.89

41.65

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

586

1953

1.89

41.62

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

194

389

3.13

41.54

1.4

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

171

317

3.39

41.30

1.4

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

11454

63351

1.17

41.30

1.3

1.7

1.8

u/ml

0.30

2880

17346

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

589

1972

1.88

41.26

1.2

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

158

278

3.57

41.15

3.3

2.8

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

589

1974

1.88

41.14

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1471

6259

1.49

41.09

1.3

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

169

312

3.40

41.07

2.6

1.9

1.2

mmol/l

0.66

162

296

(3003740) Influenza virus B Ag [Presence] in Specimen

1055

4173

1.60

40.98

1.2

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1062

10161

0.65

40.22

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

635

6856

0.58

40.17

1.5

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

139

227

3.84

40.07

1.5

113.0

110.3

ug/l

0.09

113

185

(3034988) Calcium [Moles/volume] in Capillary blood

178

346

3.23

40.04

2.7

2.0

1.2

mmol/l

0.12

170

330

(3016018) Differential panel - Cerebral spinal fluid

750

2738

1.73

39.61

1.6

1.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

118

171

4.33

39.49

1.1

19.2

21.2

u/l

0.40

106

(3008116) Ketones [Moles/volume] in Urine by Test strip

205

442

2.91

38.96

1.6

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

206

448

2.89

38.58

10.9

7.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

892

3440

1.63

38.41

2.7

269.7

1025.3

u/ml

1.35

860

3256

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

609

2119

1.81

37.86

1.4

1.3

1.5

1.4

nmol/l

1.27

558

1917

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

257

638

2.53

37.61

1.3

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

269

684

2.47

37.49

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

490

1594

1.93

37.44

1.6

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

577

1983

1.83

37.33

2.0

1.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

847

3251

1.64

37.18

2.0

1.7

1632.0

5407.4

titre

2.43

135

(3020393) Adenovirus Ag [Presence] in Stool

129

212

3.82

36.93

1.5

1.1

—

(3003129) Base excess in Capillary blood by calculation

221

513

2.71

36.84

2.0

1.6

1.3

0.2

mmol/l

3.24

209

492

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

191

409

2.93

36.76

1.3

1.2

—

(3034426) Prothrombin time (PT)

303

826

2.31

36.36

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

285

757

2.37

36.23

2.2

1.9

3587.6

3691.7

e6/l

0.01

193

507

(3027923) C peptide [Moles/volume] in Serum or Plasma

413

1282

2.03

36.00

1.4

1.7

1.3

1.2

nmol/l

0.80

315

1018

(40768795) Lymph node Pathology biopsy report

666

2417

1.73

35.97

1.3

1.2

—

(3005033) Fetal Nuchal fold Thickness US

797

7919

0.63

35.90

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

801

7938

0.63

35.67

1.4

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

225

537

2.63

35.61

1.3

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

404

1249

2.03

35.61

1.2

288.2

343.5

u/l

0.45

373

1172

(3043238) Trisomy 21 risk [Likelihood] in Fetus

825

8098

0.63

35.19

1.5

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

5.58

35.08

1.6

185.5

184.4

ug/g

0.01

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

623

2236

1.75

34.98

1.6

1.5

25.6

33.3

5.91

379

1409

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

343

1005

2.15

34.74

2.6

2.4

57.2

53.3

umol/l

1.38

272

838

(3023410) Appearance of Cerebral spinal fluid

691

2564

1.70

34.50

1.8

1.5

—

(3011544) Albumin [Mass/volume] in Pleural fluid

105

155

4.25

34.43

1.1

1.2

17.0

17.8

g/l

0.38

133

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

481

1604

1.89

34.21

1.7

1.5

30.6

22.6

u/ml

1.82

312

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

224

545

2.58

34.18

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

43031

277660

0.88

34.13

4.5

4.1

1.4

1.5

mmol/l

285.09

39751

258274

(3033799) Differential panel - Peritoneal fluid

254

662

2.41

33.68

2.1

1.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.38

33.42

3.7

2.3

—

(3000330) Specific gravity of Urine by Test strip

2593

12562

1.31

33.34

4.3

3.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

346

1036

2.10

33.21

2.3

2.2

22.5

267.6

ug/l

1.61

333

981

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

7.77

33.00

2.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.58

32.97

3.7

2.4

—

(3016750) Collection duration of Urine

422

1364

1.95

32.93

2.4

2.0

498.0

500.2

min

0.15

297

1038

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

336

998

2.12

32.92

2.3

1.6

27.5

29.6

umol/l

2.61

322

963

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1177

5014

1.48

32.74

3.1

1.9

1.0

0.8

nmol/l

8.88

968

4239

(3004616) Nuclear Ab [Presence] in Serum

787

3067

1.62

32.59

1.3

—

(3025315) Body weight

107

168

4.00

32.55

5.5

3.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

391

1236

1.99

32.49

1.8

1.4

19.5

26.7

umol/l

5.38

373

1174

(3000012) Reticulocyte production index

394

1249

1.98

32.49

1.6

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

714

2724

1.65

32.16

1.4

1.3

19.0

35.2

nmol/l

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

421

1375

1.93

31.90

1.3

168.1

473.7

titre

1.87

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

484

1657

1.84

31.79

1.1

—

(3045414) Leukocytes [Presence] in Urine

2430

11753

1.31

31.61

2.1

1.8

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

369

1154

2.01

31.60

1.9

164.9

135.8

7.79

344

1092

(40765096) Chromosome analysis panel by Banding

225

572

2.47

31.48

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2677

13126

1.29

31.43

2.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

410

1335

1.93

31.35

1.2

1.3

76.1

71.6

titre

0.10

121

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

42929

260750

1.13

31.15

5.2

4.5

2.2

2.0

mu/l

0.60

39707

240515

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

250

672

2.34

31.06

2.0

1.8

9674.4

12911.0

e6/l

0.28

127

357

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

126

232

3.41

30.88

8.4

7.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

387

1245

1.95

30.65

1.2

1.1

88.3

86.3

u/l

0.18

310

988

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

387

1246

1.95

30.58

1.2

1.1

28.8

24.4

u/l

0.75

293

957

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

43445

279680

0.88

30.18

4.5

4.1

4.5

4.7

mmol/l

241.71

40331

261210

(3009214) Lutropin [Units/volume] in Serum or Plasma

1838

8603

1.35

29.98

1.5

1.4

10.1

10.0

u/l

0.19

1458

7002

(3039162) Centromere protein B Ab [Units/volume] in Serum

814

3267

1.57

29.86

1.3

1.2

56.0

53.4

u/ml

0.10

205

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1248

5478

1.44

29.78

1.3

1.2

44.4

43.1

u/ml

0.10

148

496

(21491868) Cryoglobulin [Mass/volume] in Serum

282

816

2.17

29.55

1.3

1.2

0.5

0.6

g/l

0.09

(3026692) Albumin [Mass/volume] in Peritoneal fluid

207

523

2.49

29.37

1.4

1.5

14.7

13.1

g/l

1.49

155

397

(3004775) Volume in Urine collected for unspecified duration

520

1870

1.75

29.10

2.5

2.2

705.0

669.1

1.02

353

1289

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

41609

252575

1.12

28.86

6.5

5.2

40.9

39.0

mmol/mol

232.57

38674

234842

(3009871) Measles virus Ab [Titer] in Serum

279

812

2.16

28.84

1.6

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

455

1578

1.81

28.74

1.1

9.4

7.7

iu/ml

0.69

102

437

(3011985) Renin [Units/volume] in Plasma

849

3473

1.54

28.66

1.6

1.5

68.1

63.8

mu/l

0.23

747

3119

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

437

1507

1.82

28.13

2.8

25.5

25.8

ug/l

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

744

2967

1.58

28.08

2.6

1.8

28.2

26.3

mg/l

0.39

239

736

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

169

397

2.67

27.71

1.3

—

(3044007) Cell count panel - Peritoneal fluid

224

605

2.32

27.60

2.3

1.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

109

197

3.47

27.51

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

6.79

27.20

1.1

0.2

g/l

0.14

(3035320) C reactive protein [Mass/volume] in Body fluid

488

1764

1.74

26.88

3.3

2.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

130

268

3.04

26.82

10.2

7.9

0.4

umol/l

0.31

119

239

(3002256) Pathology report gross observation

6500

35447

1.17

26.73

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

153

3.81

26.72

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

139

3.97

26.65

2.8

2.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

505

1848

1.72

26.65

1.3

1.2

11.5

9.6

u/ml

0.12

135

(3010144) Erythrocytes [#/volume] in Synovial fluid

585

2230

1.65

26.54

1.5

1.3

135699.1

103995.0

e6/l

0.47

391

1521

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

523

1935

1.70

26.53

1.3

1.2

35.4

47.0

u/ml

0.65

139

(3011288) Drugs identified in Urine by Screen method

1808

8598

1.33

26.52

5.0

2.6

—

(3038026) Centromere Ab [Units/volume] in Serum

532

1978

1.69

26.51

1.3

1.2

43.0

51.9

u/ml

0.23

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

219

597

2.30

26.46

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

367

1221

1.89

26.44

1.5

1.2

60.6

68.8

0.91

124

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

521

1931

1.70

26.27

1.3

1.2

74.0

65.6

u/ml

0.23

(1761482) Bacteria [#/volume] in Urine by Culture

1361

6211

1.38

26.06

5.2

3.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

413

1434

1.81

26.05

1.2

—

(36660697) Celiac disease serology panel - Serum

4301

22688

1.20

26.01

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

215

588

2.30

25.80

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

7.62

25.74

10.0

7.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

215

589

2.29

25.71

1.1

—

(3002619) Bacteria identified in Specimen by Culture

174

436

2.50

25.20

1.3

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

101

4.47

25.18

4.3

3.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

541

2055

1.66

24.91

1.2

1.1

60.8

63.2

u/ml

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

200

540

2.33

24.73

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

200

540

2.33

24.73

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

200

540

2.33

24.73

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

200

540

2.33

24.73

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

4.55

24.66

10.5

10.1

312.5

360.5

e6/l

0.08

(1001926) Buprenorphine [Presence] in Urine by Screen method

2026

9887

1.29

24.65

3.4

2.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1254

10652

0.73

24.50

1.5

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

339

1132

1.88

24.21

1.6

1.4

3.3

4.6

0.92

245

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2284

11350

1.27

24.09

1.1

19.1

6.7

u/ml

0.51

166

(3003327) Ova and parasites identified in Stool by Light microscopy

1928

9382

1.30

23.97

1.7

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

5.26

23.71

1.1

1.3

0.1

g/l

0.30

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

133

3.82

23.39

8.4

3.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

678

2764

1.54

23.35

1.1

26.8

23.5

au/ml

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

7.56

23.32

6.2

4.6

8.9

6.7

mg/l

0.27

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

665

2704

1.55

23.17

1.1

51.7

81.4

au/ml

—

(40768441) Liver Pathology biopsy report

483

1816

1.67

23.17

1.4

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

44321

284045

0.89

23.11

4.9

4.5

2.7

2.8

mmol/l

214.64

40911

263862

(3024263) Appearance of Synovial fluid

353

1215

1.83

22.98

1.8

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

145

348

2.61

22.92

7.5

7.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

209

595

2.21

22.92

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

177

469

2.37

22.86

1.5

1.3

35.3

26.4

g/l

0.56

135

373

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

356

1232

1.82

22.78

7.2

5.2

134.3

4453.9

u/ml

0.77

204

(40768443) Skin Pathology biopsy report

2309

11575

1.26

22.64

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

110

228

3.03

22.58

1.3

1.1

—

(3036603) Volume of Urine

451

1678

1.69

22.51

1.8

1.6

1842.3

1971.8

0.76

110

375

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.28

22.47

6.1

3.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

733

3068

1.50

22.38

1.4

1.3

—

nmol/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

196

549

2.24

22.35

1.1

—

(3012898) Urea [Moles/volume] in Urine

108

223

3.04

22.32

1.5

1.7

163.6

174.6

mmol/l

0.35

198

(40761511) CBC panel - Blood by Automated count

48545

298498

1.14

22.30

22.9

10.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

458

4617

0.62

22.13

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

106

218

3.05

22.05

2.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

511

1982

1.62

21.77

1.3

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

382

1370

1.75

21.75

1.9

1.7

2.4

2.3

u/field

0.06

282

975

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

240

739

2.04

21.64

1.4

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

257

814

1.98

21.47

1.1

87.5

93.1

1.08

136

378

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

484

1861

1.63

21.35

1.4

13.6

11.6

umol/l

6.65

453

1763

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

133

317

2.63

21.35

1.2

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

186

520

2.25

21.33

1.1

1.2

91.1

86.1

0.57

122

(3006442) Creatine [Moles/volume] in Serum or Plasma

444

1671

1.67

21.27

1.8

1.4

66.8

69.9

umol/l

0.41

141

(3045424) Erythrocytes [Presence] in Urine

979

4381

1.41

21.12

1.6

1.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

457

1740

1.65

20.96

3.3

3.1

25.3

27.0

mu/l

0.36

424

1624

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

215

3.00

20.94

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

267

865

1.94

20.94

1.9

2.0

195.8

156.7

5.82

256

810

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

264

852

1.95

20.93

1.1

1.2

104.4

108.3

0.71

247

772

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

185

521

2.23

20.87

1.1

1.2

78.4

75.1

0.32

121

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

9.72

20.86

4.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

260

836

1.95

20.83

1.1

87.3

92.2

1.29

137

386

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

290

970

1.88

20.70

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

186

527

2.22

20.69

1.9

2.0

16.4

16.7

umol/l

0.11

186

527

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

112

248

2.83

20.60

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

269

880

1.92

20.52

2.8

2.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

144

365

2.48

20.49

1.2

1.1

3.3

7.9

pmol/l

0.51

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

4.94

20.35

1.4

1.1

—

(3042517) Benzodiazepines panel - Urine

126

300

2.63

20.29

2.6

3.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

115

3.82

20.26

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

109

242

2.83

19.97

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

582

2378

1.54

19.93

4.5

3.6

60.0

47.6

u/ml

0.72

577

2346

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

814

3576

1.43

19.51

1.3

1.7

1.1

nmol/l

0.22

759

3453

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

5.85

19.40

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

114

264

2.71

19.37

2.4

2.3

1.1

1.5

mmol/l

0.99

187

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.99

19.32

1.1

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

754

3272

1.45

19.30

1.3

1.4

307.0

305.4

pmol/l

0.02

577

2556

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

809

3559

1.43

19.25

1.3

0.2

0.3

nmol/l

0.05

206

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

187

549

2.14

19.13

1.6

1.5

0.4

ug/l

0.17

128

366

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

666

2826

1.48

19.11

3.3

7.4

5.5

nmol/l

1.18

641

2748

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

536

2171

1.55

19.11

2.0

2.2

18.5

19.4

nmol/l

0.96

501

2073

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

176

507

2.18

18.87

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

138

3.41

18.60

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

738

3221

1.44

18.35

1.4

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

192

2.97

18.24

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

524

4918

0.66

18.24

1.4

1.3

3.1

3.7

ug/l

1.95

450

4437

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

313

1117

1.76

18.23

2.1

103.7

83.9

ug/min

0.36

253

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

111

263

2.65

18.10

1.2

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

125

315

2.49

18.06

1.5

1.6

—

(40758292) HTLV I+II Ab panel - Serum

143

385

2.33

17.96

1.5

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

121

301

2.52

17.95

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1096

5134

1.34

17.93

2.0

1.8

189.4

193.2

pmol/l

0.50

1038

4877

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.54

17.92

1.1

1.2

—

(46236302) HLA-C [Type] by High resolution typing

4.75

17.70

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

226

734

1.93

17.69

1.3

1.2

28.1

15.4

1.58

121

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

183

552

2.08

17.54

1.2

110.8

107.3

0.58

174

519

(3014051) Protein [Presence] in Urine by Test strip

1220

5825

1.32

17.53

2.5

2.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

187

2.95

17.45

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

536

2217

1.52

17.44

3.1

2.9

85.3

42.4

mg/l

1.75

407

1562

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

584

2466

1.49

17.23

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

491

1998

1.54

17.21

2.2

2.0

2.1

2.4

u/field

0.64

245

857

(3007463) Buprenorphine [Presence] in Urine

3.87

17.15

6.9

5.9

—

(3036670) Protein [Mass/volume] in Synovial fluid

205

652

1.97

17.06

1.3

1.2

38.5

40.8

g/l

1.22

117

332

(40760409) HLA-A [Type] by High resolution

4.65

16.94

1.0

—

(40760410) HLA-B [Type] by High resolution

4.65

16.94

1.0

—

(40763590) HLA-DQ beta [Type]

4.65

16.94

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

140

384

2.29

16.90

1.4

1.3

46.6

211.2

titre

1.40

(3013862) HLA-DP [Type]

4.58

16.65

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1381

6766

1.29

16.41

1.7

1.9

63.4

13.1

iu/l

0.56

443

2567

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

167

3.00

16.37

1.3

0.9

1.8

ml/s/173m2

1.08

103

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

124

327

2.38

16.35

1.2

1.5

70110.5

223623.6

nmol/l

0.81

271

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1436

11338

0.79

16.34

1.9

1.6

5.6

3.1

mg/l

8.07

1123

7667

(3020491) Glucose [Moles/volume] in Blood

479

1963

1.53

16.30

2.1

1.6

7.3

6.5

mmol/l

5.24

355

1416

(3051593) INR in Capillary blood by Coagulation assay

285

1024

1.75

16.28

8.3

10.3

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

111

3.50

16.05

1.1

1.2

u/field

0.03

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

118

307

2.41

16.02

1.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

152

3.05

15.57

1.2

100.7

102.3

ug/l

0.03

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3141

16855

1.18

15.51

1.3

37.0

53.4

au/ml

3.23

735

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

902

4198

1.35

15.47

4.3

3.3

41.1

36.5

u/ml

0.37

876

4040

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

49137

303374

1.12

15.42

15.3

8.8

27.3

26.1

u/l

11.01

47909

292574

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.15

15.21

2.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

116

309

2.35

15.01

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

634

2798

1.42

14.96

1.1

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2819

15043

1.18

14.87

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

199

661

1.89

14.69

2.2

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1971

10194

1.22

14.58

1.7

1.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.01

14.39

3.5

3.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3403

18491

1.16

14.35

2.4

24.3

au/ml

0.01

136

1203

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

116

316

2.30

14.31

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

405

1651

1.54

14.20

1.2

1.1

ratio

1.21

134

592

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1124

5467

1.29

14.19

1.8

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3221

23235

0.86

14.05

2.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

326

1266

1.62

14.05

1.2

1.1

19.4

10.8

u/ml

0.45

126

(3045462) Protein/Creatinine [Ratio] in Urine

223

2.56

14.03

5.5

4.7

39.6

306.4

g/mol

0.65

201

(40763791) Oxygen content in Venous blood by calculation

4.73

13.93

5.4

6.8

12.1

13.0

ml/dl

0.52

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

41853

267480

0.92

13.88

4.1

3.7

1.4

1.3

mmol/l

171.19

38427

247451

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7645

43807

1.11

13.85

2.8

3.0

0.7

0.8

ug/l

2.16

5115

28756

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

185

2.71

13.78

1.3

15.3

12.5

pmol/l

0.33

156

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

5.07

13.77

11.6

6.6

39.5

45.4

0.44

(3000963) Hemoglobin [Mass/volume] in Blood

50908

322345

0.89

13.69

37.0

16.1

131.6

136.2

g/l

307.65

50357

317873

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

226

2.53

13.67

1.5

1.1

22.0

20.8

mmol/l

1.74

180

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.11

13.49

1.0

1.3

4036.3

2773.0

ng/l

0.29

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.55

13.35

1.1

—

mmol/l

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

312

1217

1.61

13.24

1.7

1.6

3.9

9.8

nmol/l

0.67

266

1026

(3030313) Adrenal Ab [Titer] in Serum

245

2.43

13.23

1.1

—

(3016879) Cocaine [Presence] in Urine

2277

12051

1.19

13.23

3.3

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1153

5681

1.28

13.19

4.8

2.9

33.1

24.9

mg/l

9.49

819

3414

(3029075) Extractable nuclear Ab panel - Serum

217

768

1.77

13.17

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

4891

34162

0.89

13.12

1.7

—

(4212803)

176

2.71

13.08

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

50902

322219

0.89

12.98

36.7

16.0

4.4

4.5

e12/l

307.65

49824

312329

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

9.92

12.93

1.7

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

412

1722

1.50

12.93

1.4

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5758

39811

0.90

12.92

2.2

2.1

—

(3024731) MCV [Entitic volume]

50898

322184

0.89

12.90

36.6

16.0

91.0

90.6

57.32

50351

317620

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

413

1728

1.50

12.89

1.2

1.1

—

(3010813) Leukocytes [#/volume] in Blood

50915

322284

0.89

12.89

36.8

16.1

7.4

6.6

e9/l

307.65

49831

312380

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

409

1709

1.50

12.85

1.4

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

4.02

12.80

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

147

462

2.00

12.79

4.4

6.6

65.4

71.2

1.51

101

380

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

251

2547

0.62

12.73

1.5

—

(3035941) MCH [Entitic mass]

50898

322140

0.89

12.56

36.5

16.0

30.2

9.29

50346

317597

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

108

304

2.23

12.43

1.2

1.4

41.2

55.0

1.89

152

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

241

2.39

12.43

2.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

169

565

1.88

12.33

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

123

367

2.10

12.29

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

459

1982

1.45

12.28

1.1

300.3

438.6

mg/l

0.45

420

1776

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

149

478

1.96

12.27

1.3

1.2

65.4

43.0

mg/l

0.19

110

347

(3022229) Phosphate [Moles/volume] in Urine

128

2.94

11.96

1.6

2.5

20.4

18.9

mmol/l

0.18

109

(44806071)

109

314

2.18

11.90

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

146

2.79

11.86

2.3

2.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

184

641

1.80

11.82

1.5

1.2

17.5

16.6

umol/l

1.24

165

577

(3019420) Tryptase [Mass/volume] in Serum or Plasma

337

1377

1.54

11.80

1.6

1.5

11.1

7.8

ug/l

1.05

298

1254

(3010838) Calcium [Moles/time] in 24 hour Urine

308

1236

1.56

11.68

1.5

1.6

5.8

5.6

mmol/24h

0.07

(3010015) Selenium [Moles/volume] in Serum or Plasma

206

2.47

11.67

2.2

1.9

1.2

1.3

umol/l

1.26

182

(3005570) Glucose [Moles/volume] in Urine

580

2641

1.38

11.56

2.1

1.8

10.4

3.2

mmol/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

869

4207

1.30

11.47

1.1

50.5

861.5

iu/ml

1.47

195

956

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2559

18476

0.86

11.29

1.9

1.8

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

5.43

11.29

1.0

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

191

2.49

11.24

1.1

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

166

570

1.83

11.20

1.3

1.2

406.9

323.8

pmol/l

0.37

116

431

(3007461) Platelets [#/volume] in Blood

50883

321861

0.90

11.18

36.8

16.1

256.5

253.0

e9/l

23.07

49935

312869

(3019897) Erythrocyte distribution width [Ratio] by Automated count

510

4392

0.72

11.13

4.3

2.3

13.3

13.1

3.91

505

4333

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

117

2.95

11.05

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1480

7659

1.22

10.99

1.8

1.7

40.0

42.5

nmol/l

3.24

1441

7472

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

108

321

2.11

10.96

1.7

1.5

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

10.03

10.94

1.1

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

4.10

10.92

6.3

5.4

1.1

1.2

mg/l

0.15

(3035933) Granulocytes/100 leukocytes in Blood

199

728

1.72

10.88

2.8

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

115

352

2.05

10.83

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

341

1425

1.50

10.81

1.1

5.4

5.6

nmol/l

0.04

265

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

145

487

1.87

10.52

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.28

10.51

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

258

2.21

10.39

2.7

2.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.21

10.37

22.8

8.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

134

445

1.89

10.08

2.4

7.8

7.3

mmol/l

0.68

263

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

238

933

1.60

10.04

1.3

1.4

16.0

14.5

pmol/l

1.21

203

783

(3009542) Hematocrit [Volume Fraction] of Blood

43243

266490

1.07

10.00

26.6

11.7

39.0

40.0

102.20

30581

200451

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

133

443

1.88

9.92

1.5

1.6

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

170

613

1.74

9.83

1.6

1.3

34.6

39.8

0.94

114

400

(3000764) Benzodiazepines [Presence] in Urine

2387

13022

1.15

9.61

3.3

1.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

176

648

1.70

9.48

1.3

1.2

127.0

121.9

nmol/l

0.16

122

481

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

193

2.34

9.38

2.7

2.1

57.2

57.7

0.03

122

(3020618) Glucose [Moles/volume] in Synovial fluid

3.47

9.35

1.1

1.0

5.7

5.2

mmol/l

0.30

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5248

35873

0.91

9.29

2.1

2.0

—

(3028300) Cannabinoids [Presence] in Urine

2403

13150

1.15

9.27

3.3

1.9

—

(3028717) Thiamine [Mass/volume] in Blood

247

2.16

9.20

1.1

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

456

2077

1.38

9.19

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

299

1261

1.49

9.16

1.1

1510.2

1527.2

miu/ml

0.09

299

1261

(3027008) Opiates [Presence] in Urine

2395

13119

1.15

9.12

3.3

1.9

—

(3042951) Complement C1q Ab [Units/volume] in Serum

113

2.77

9.12

1.3

1.2

29.9

14.2

u/ml

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

251

1021

1.54

9.10

1.1

683.0

483.5

ng/l

0.26

228

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

224

890

1.58

9.00

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

748

0.42

8.98

1.2

—

(3018133) Calcium [Moles/volume] in Urine

124

418

1.86

8.97

2.0

2.1

2.3

2.7

mmol/l

1.22

109

376

(3005082) Progesterone [Moles/volume] in Serum or Plasma

197

1939

0.64

8.91

1.3

1.4

29.7

32.0

nmol/l

0.56

174

1796

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

153

2.46

8.72

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

291

2.03

8.69

2.1

1.9

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

290

2625

0.69

8.64

1.6

7.8

7.5

mmol/l

0.78

183

1423

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

11976

71177

1.07

8.64

1.7

1.6

1.5

1.3

mmol/l

51.32

10276

60142

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

222

2.17

8.53

1.3

1.2

48.9

47.9

mg/l

0.06

(3027540) Rickettsia typhi Ab [Titer] in Serum

4.42

8.48

1.0

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

192

747

1.61

8.45

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

225

913

1.55

8.30

2.2

1.9

8.3

9.6

mg/l

2.61

186

721

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

142

2.47

8.25

1.3

1.6

11.6

13.1

0.20

104

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

120

2.61

8.21

1.2

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

139

500

1.74

8.20

1.3

154.1

62.7

mu/l

0.98

104

378

(3024869) Neuronal Ab [Presence] in Serum

122

423

1.81

8.13

1.1

—

(3009992) Blasts/100 cells in Bone marrow

13.43

8.11

1.8

1.4

11.9

32.7

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

163

2.35

8.06

1.3

1.6

46.3

35.1

1.19

111

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

372

1677

1.39

8.05

3.5

3.3

151.7

123.4

nmol/l

0.74

363

1653

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.23

8.00

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

233

963

1.52

7.93

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

347

1551

1.40

7.90

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.48

7.87

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

458

2145

1.34

7.82

1.1

296.7

262.2

mg/l

0.94

402

1893

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

127

2.52

7.81

1.3

1.4

1686.3

946.7

u/l

0.22

112

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

185

728

1.59

7.81

1.7

1.6

73.8

163.5

au/ml

2.77

(3039744) RNA polymerase III Ab [Units/volume] in Serum

210

2.15

7.80

1.1

1.0

8.3

2.2

u/ml

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.23

7.78

1.1

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.37

7.77

1.2

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

174

2.27

7.76

1.1

15.0

16.8

iu/ml

0.08

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

279

1204

1.45

7.71

1.1

97.2

96.5

0.13

239

943

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

121

427

1.78

7.65

4.5

5.0

45.8

55.4

u/l

0.51

162

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4927

33466

0.91

7.57

1.7

1.8

—

(3027944) Amphetamines [Presence] in Urine

2334

12936

1.14

7.53

3.0

1.9

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

471

2229

1.33

7.52

1.2

1.1

49.7

42.7

mg/l

0.70

394

1873

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

157

2.32

7.48

1.1

1.2

39.6

14.4

1.34

(4027681)

374

1714

1.37

7.38

1.3

1.2

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

120

2.51

7.32

1.2

1.4

2.8

1.2

0.93

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

222

926

1.50

7.29

1.9

2.7

1.0

1.2

ug/l

0.48

210

888

(3033923) Metanephrine [Moles/time] in 24 hour Urine

137

510

1.68

7.22

1.1

0.7

3.6

umol/24h

0.53

258

(3011325) HIV 1+2 Ab [Presence] in Serum

110

2.56

7.18

1.0

1.1

—

(3019174) dRVVT (LA screen)

223

2.05

7.08

1.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.92

7.08

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

355

1627

1.37

7.03

2.1

1.8

—

(4024509)

498

2400

1.30

7.02

1.6

1.5

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

112

2.52

6.94

1.0

1.1

21.0

21.8

0.54

102

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

112

2.52

6.94

1.0

1.1

36.5

35.9

0.26

103

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

112

2.52

6.94

1.0

9.0

8.9

0.07

102

(3013293) Extractable nuclear Ab [Presence] in Serum

107

376

1.78

6.91

1.7

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

256

1.96

6.86

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

121

2.43

6.78

1.0

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

198

823

1.51

6.66

1.4

1.2

112.4

111.4

0.18

174

730

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

152

595

1.60

6.64

1.4

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.61

6.64

1.0

0.1

0.2

u/ml

0.40

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

219

931

1.48

6.61

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

242

1050

1.45

6.58

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

107

382

1.76

6.58

2.5

2.9

2092.1

1325.5

u/l

0.43

349

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

269

1.91

6.57

3.4

3.0

18.7

24.2

mg/l

3.55

256

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.84

6.57

1.1

1.0

u/field

0.12

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

208

877

1.49

6.54

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

122

453

1.69

6.54

1.1

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

4.25

6.45

1.3

1.4

0.8

0.6

u/field

0.31

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.41

6.41

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

277

1239

1.40

6.39

1.2

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

263

1.91

6.38

3.4

3.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

329

1515

1.36

6.38

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.62

6.35

9.7

8.2

—

(3006270) Folate [Moles/volume] in Blood

453

2189

1.30

6.32

1.2

1.1

340.3

374.8

nmol/l

2.45

372

1879

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.64

6.26

1.0

0.1

u/ml

0.04

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

260

1.88

6.00

1.6

1.7

1.6

1.7

mg/l

0.41

224

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

149

2.19

5.98

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.97

5.96

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

263

1185

1.39

5.86

1.1

9.2

u/ml

0.01

192

(3041806) Other cells [#/volume] in Blood by Manual count

162

1507

0.67

5.77

1.6

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

233

1.91

5.74

1.3

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

908

4792

1.19

5.71

1.1

2.7

2.1

u/ml

0.63

268

1152

(3036071) Salmonella sp Ab [Titer] in Serum

199

857

1.46

5.70

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

135

537

1.58

5.60

2.3

2.5

—

(3028468) Fragments [Presence] in Blood by Light microscopy

5.78

5.54

2.4

1.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

102

379

1.69

5.53

1.1

—

(4034850)

1566

8642

1.14

5.51

12.9

8.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

333

1.73

5.48

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

155

2.10

5.46

3.8

4.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

204

895

1.43

5.33

1.4

1.2

0.3

g/l

1.26

166

694

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

262

1.82

5.32

1.1

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

132

2.18

5.31

1.1

2.5

3.3

u/l

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

175

747

1.47

5.28

1.5

1.4

59.7

53.2

1.46

146

644

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

145

596

1.53

5.24

1.2

—

(4146454)

530

2678

1.24

5.22

2.7

2.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

138

2.13

5.15

1.0

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

3.07

5.09

1.8

1.6

464.2

221.1

nmol/l

0.75

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.45

5.06

1.1

1.4

1.2

u/field

0.05

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1058

5721

1.16

5.01

1.1

2.5

1.8

u/ml

0.85

512

2240

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.81

4.99

1.6

444.8

214.4

nmol/l

0.89

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

269

1.77

4.92

1.1

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

316

1.71

4.90

2.5

2.3

0.7

0.6

u/field

0.26

316

(3009015) Lactate [Moles/volume] in Synovial fluid

233

1.83

4.89

1.2

1.3

6.2

5.9

mmol/l

0.15

106

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

142

2.07

4.82

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

119

2.16

4.65

1.0

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

157

2.00

4.65

3.0

2.0

13.9

18.7

0.47

(37019676) Renin [Units/volume] in Plasma --supine

2.88

4.63

1.0

1.1

81.7

49.2

mu/l

0.29

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

153

2.01

4.63

1.4

1.3

15.2

17.0

pmol/l

0.34

130

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

679

3566

1.20

4.61

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1128

6173

1.15

4.57

1.4

1.3

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

180

1.92

4.57

1.2

1.1

15.1

15.9

nmol/l

0.11

(3007916) DNA double strand Ab [Titer] in Serum

304

1.69

4.56

1.6

1.2

271.4

124.7

titre

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

207

940

1.38

4.52

2.5

2.7

157.1

156.0

au/ml

0.01

120

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.32

4.50

1.1

—

(3001729) Color of Synovial fluid

181

1.90

4.50

1.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

226

1043

1.36

4.47

2.9

3.2

8.3

8.2

mg/l

0.08

175

832

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

186

1.89

4.46

1.3

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

191

1.87

4.43

1.0

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

152

1.98

4.38

1.7

0.7

0.8

0.16

119

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

271

0.35

4.38

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

174

1.91

4.38

1.1

10.6

9.9

u/l

0.11

174

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.30

4.34

1.3

1.4

687.6

467.9

nmol/l

1.00

(3027570) Oxalate [Moles/time] in 24 hour Urine

157

1.96

4.34

1.3

1.5

348.9

313.0

umol/24h

0.39

157

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

316

1538

1.29

4.34

1.1

u/l

0.47

130

698

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.47

4.29

1.4

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1977

11239

1.11

4.27

1.7

1.6

339.0

309.5

mu/l

2.27

1772

10130

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

4.07

4.24

1.0

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

236

1107

1.34

4.23

1.2

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1814

10278

1.11

4.19

1.9

1.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

951

5183

1.15

4.13

1.1

5.9

5.6

u/ml

0.23

562

2605

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.57

4.13

1.0

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.29

4.05

1.1

193.5

221.0

pmol/l

0.13

(3008401) Mugwort IgE Ab [Units/volume] in Serum

905

4926

1.15

4.02

1.1

u/ml

0.12

450

2033

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

254

1.70

3.99

1.1

1.8

3.1

umol/24h

0.46

254

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1457

8185

1.12

3.96

1.1

7.8

4.9

u/ml

0.98

139

1147

(44813793)

382

1927

1.24

3.94

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.65

3.87

1.8

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

169

1444

0.73

3.85

1.3

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

7.05

3.82

1.1

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

7.05

3.82

1.1

1.0

—

(3022689) Creatine [Moles/volume] in Urine

158

709

1.40

3.78

1.7

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

182

837

1.36

3.76

1.0

—

(3017400) Magnesium [Moles/volume] in Urine

2.60

3.75

1.2

1.3

3.1

2.9

mmol/l

0.12

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

956

6808

0.88

3.72

1.5

1.4

148.0

127.1

pmol/l

0.66

933

6647

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

153

1.88

3.71

1.3

1.2

7.8

5.0

u/ml

0.18

125

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

4.48

3.62

1.1

1.4

—

(3041184) Isoniazid [Presence] in Urine

3.37

3.61

2.9

2.7

—

(3017509) Phencyclidine [Presence] in Urine

335

1.57

3.60

2.0

1.8

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

414

1.50

3.46

1.6

1.8

43.3

62.5

pmol/l

0.78

343

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

313

1573

1.25

3.40

1.0

266.8

357.0

ng/l

2.99

226

1123

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

140

1.88

3.40

1.1

68.2

102.2

u/l

0.26

111

(3034092) Cytoplasmic Ig cells/100 cells in Blood

371

1.52

3.37

14.2

5.7

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

154

1.83

3.37

1.2

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

144

652

1.38

3.32

1.1

—

(3024316) Viscosity of Plasma

119

1.95

3.32

2.1

1.5

1.6

1.7

mpas

0.31

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

170

1.77

3.23

1.0

1.1

36.2

29.2

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

170

1.77

3.23

1.0

1.1

25.1

24.4

u/ml

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2366

13749

1.08

3.23

1.1

111.7

193.8

titre

2.00

390

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1703

9762

1.10

3.20

1.3

209.7

227.2

miu/ml

1.06

629

4666

(3020123) Porphyrins [Interpretation] in Serum or Plasma

148

1.82

3.18

1.2

1.1

—

(3051339) Copper [Moles/volume] in Blood

117

1.93

3.15

1.3

16.1

16.8

umol/l

0.42

105

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

5.13

3.15

1.0

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

312

1584

1.24

3.13

1.0

747.3

735.9

ng/l

0.16

211

1093

(3043614) Bacteria identified in Aspirate by Culture

7.31

3.13

1.0

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.24

3.08

3.7

2.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

312

1588

1.23

3.07

1.0

41.2

43.0

ng/l

0.10

218

1117

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

2.56

3.02

1.4

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

156

731

1.34

2.95

1.7

1.6

9.7

8.9

ug/l

1.22

156

731

(3035082) Kappa light chains [Mass/volume] in Urine

2.43

2.89

1.2

1.1

0.5

0.1

g/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

564

4082

0.86

2.88

1.3

7.3

7.0

mmol/l

1.18

413

2858

(3038177) Helicobacter pylori Ab [Presence] in Serum

848

4719

1.13

2.83

1.2

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

118

1.86

2.79

1.2

1.3

—

11951.3

—

(3030703) Everolimus [Mass/volume] in Blood

7.52

2.77

24.2

10.2

4.4

4.3

ug/l

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

198

1.65

2.77

5.4

2.3

15.1

11.8

0.46

(3049233) Organic acids panel - Urine

2.91

2.73

1.5

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

104

463

1.41

2.72

1.5

0.2

nmol/l

1.16

337

(3013247) Albumin in CSF/Albumin in Serum or Plasma

134

623

1.35

2.70

1.1

7.1

7.0

mg/g

0.07

124

596

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5441

32647

1.05

2.70

10.9

5.9

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

162

1.70

2.66

1.4

—

(3000285) Sodium [Moles/volume] in Blood

310

1.50

2.65

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.97

2.65

1.3

1.1

324.1

253.1

nmol/l

0.61

(1002224) Polysomnography panel

1995

11628

1.08

2.59

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

3.13

2.58

1.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.54

2.51

1.1

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

614

4368

0.88

2.50

1.5

1.6

—

(3025130) Human papilloma virus identified in Specimen

628

4459

0.88

2.48

1.7

—

(4094501)

1031

7119

0.91

2.48

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

738

4118

1.12

2.42

1.1

1.0

5.3

3.9

u/ml

0.86

351

1562

(3036312) Salmon IgE Ab [Units/volume] in Serum

153

1.68

2.39

1.0

1.1

1.3

0.9

u/ml

0.23

110

(3006969) Lambda light chains [Mass/volume] in Urine

2.32

2.38

1.1

1.0

0.0

0.1

g/l

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.12

2.31

1.0

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1465

8480

1.08

2.31

1.9

1.7

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.89

2.25

1.9

2.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

366

1.40

2.19

1.1

0.3

0.4

u/ml

0.32

221

(3011048) Pyruvate [Moles/volume] in Blood

153

1.64

2.16

1.3

1.5

86.5

79.4

umol/l

0.50

139

(3023430) Cat dander IgE Ab [Units/volume] in Serum

689

3860

1.12

2.16

1.1

1.0

4.8

5.0

u/ml

0.15

339

1567

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

3.99

2.13

1.0

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.99

2.13

1.0

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

358

1.40

2.11

2.7

72.7

67.9

pmol/l

0.11

311

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

592

3298

1.13

2.06

1.1

1.0

0.4

0.3

u/ml

0.25

185

638

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.09

2.03

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.97

1.99

1.1

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

5.22

1.96

2.6

1.8

—

(3027874) Urate [Moles/volume] in Urine

1.87

1.95

1.2

1.0

1.5

10.4

mmol/l

0.51

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

256

1899

0.84

1.93

1.3

1.4

1.5

g/l

0.49

108

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

361

1.37

1.89

2.1

2.5

—

(3025577) Chromium [Mass/volume] in Blood

276

1467

1.18

1.88

2.0

2.1

2.3

2.4

ug/l

0.07

224

1234

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

638

3592

1.11

1.88

1.6

—

(3013762) Body weight Measured

1.74

1.86

1.2

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

148

741

1.25

1.84

1.6

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

802

4577

1.10

1.83

1.3

25.1

26.2

u/l

0.48

658

3797

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.82

1.0

0.0

0.2

u/ml

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

141

1.60

1.82

1.1

1.0

3.9

4.1

kpa

0.08

118

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

156

1.57

1.81

1.0

0.5

u/ml

0.40

140

(3013945) Hepatitis B virus e Ab [Presence] in Serum

161

1.56

1.81

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2303

15217

0.95

1.81

1.4

1.3

24.9

27.5

iu/l

3.57

1929

13085

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

163

827

1.24

1.81

1.1

1.0

7.4

9.8

u/ml

0.61

109

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

722

4981

0.91

1.81

1.5

1.4

0.4

nmol/l

1.21

539

3973

(3036180) Methadone [Presence] in Urine

1.98

1.79

1.6

3.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.61

1.78

3.1

2.0

—

(3004959) Base excess in Arterial cord blood by calculation

142

1.59

1.78

1.1

1.0

-0.6

-2.7

mmol/l

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

4.48

1.77

4.2

2.7

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

2.46

1.77

1.1

1.4

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

2.46

1.77

1.1

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

252

1339

1.18

1.75

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5310

32181

1.04

1.72

4.5

4.3

31.9

32.5

3.08

3902

22170

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

195

0.55

1.70

1.2

1.3

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

2.14

1.69

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

281

1512

1.17

1.69

1.9

2.0

3.5

3.7

ug/l

0.09

247

1334

(3011897) Casein IgE Ab [Units/volume] in Serum

451

1.31

1.67

1.2

2.2

9.0

u/ml

0.78

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

145

1.56

1.65

1.1

1.0

7.3

7.1

kpa

0.24

123

(3006598) pH of Arterial cord blood

145

1.56

1.65

1.1

1.0

—

(4133840)

148

755

1.23

1.60

1.3

1.2

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.64

1.60

1.1

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

102

1.66

1.59

1.1

1.2

—

(3008898) HLA-B27 [Presence]

1674

9892

1.06

1.59

1.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.88

1.58

1.6

1.7

132.8

113.5

ug/l

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.00

1.56

1.1

—

(3018291) Platelet Ab [Presence] in Serum

2.04

1.53

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.85

1.52

1.1

1.0

—

(3034614) HLA Ag [Interpretation]

1.85

1.52

1.4

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

487

2744

1.11

1.49

1.3

12.0

11.8

mmol/l

0.17

185

576

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.96

1.48

1.0

162.8

164.9

g/l

0.17

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

383

0.70

1.48

1.2

1.4

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.48

1.47

1.2

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

100

494

1.27

1.46

1.2

1.1

8.5

7.6

u/ml

0.08

349

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.32

1.45

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.32

1.45

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.32

1.45

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.32

1.45

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.32

1.45

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.32

1.45

2.0

—

(3003694) ABO and Rh group [Type] in Blood

13524

83297

1.02

1.44

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

189

0.60

1.36

1.0

—

(3032641) Amino acids panel - Urine

2.24

1.35

1.7

1.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

285

1.34

1.35

1.0

0.2

u/ml

0.26

178

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

200

1.41

1.34

1.0

2.4

1.1

u/ml

0.42

131

(3015183) Erythrocyte sedimentation rate

203

1480

0.86

1.34

1.2

—

(3006462) Nitrate [Presence] in Urine

244

1329

1.15

1.32

3.3

2.9

—

(3049242) von Willebrand panel - Platelet poor plasma

1.67

1.30

1.4

1.7

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

114

1.54

1.28

1.6

1.5

0.2

u/l

0.10

(40768800) Prostate Pathology biopsy report

700

4743

0.92

1.27

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

646

4391

0.92

1.27

1.5

—

(36303858) Crystals [Presence] in Urine

2.16

1.26

1.0

1.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

161

1.44

1.25

1.0

0.9

1.4

u/ml

0.25

116

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

2.85

1.24

1.0

1.2

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.51

1.23

1.0

1.1

15.3

17.3

umol/l

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

209

1.38

1.23

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

119

0.53

1.20

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

189

1.39

1.20

1.0

1.1

0.8

0.7

u/ml

0.06

115

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

43388

270575

1.02

1.19

4.8

4.2

6.1

5.8

mmol/l

174.73

39787

248837

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.09

1.18

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

145

1071

0.85

1.17

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.65

1.16

1.0

—

(3003338) MCHC [Mass/volume]

39589

249330

0.98

1.14

32.1

13.9

331.1

332.9

g/l

236.67

39250

247451

(40762814) Titanium [Mass/volume] in Blood

416

1.25

1.14

2.4

2.3

3.7

3.8

ug/l

0.06

148

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

394

1.26

1.13

1.1

1.0

77.7

81.9

ug/l

0.36

326

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

355

1.27

1.13

1.2

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.69

1.13

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

108

1.51

1.11

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

2.31

1.11

1.0

1.1

—

(4211845)

264

1471

1.12

1.07

3.3

2.8

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

110

1.48

1.04

1.2

1.1

299.9

392.0

u/l

0.30

(1617658) Protocol used for examination of sentinel lymph nodes

299

2076

0.90

0.99

1.1

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

152

821

1.16

0.99

1.1

1.9

7.9

u/ml

1.17

468

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

164

1.38

0.99

1.2

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

274

1.28

0.97

1.0

1.1

2.1

4.3

u/ml

0.52

208

(44806420)

121

644

1.18

0.96

2.1

2.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

296

1676

1.11

0.94

1.4

1.2

4.5

5.1

umol/l

2.11

268

1553

(3032868) Hemoglobin electrophoresis panel in Blood

260

1.28

0.91

1.6

—

(3010937) Rubella virus Ab [Presence] in Serum

178

1.34

0.90

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

130

1.40

0.89

1.3

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

306

2107

0.91

0.89

1.4

1.3

96.4

88.3

pmol/l

0.15

138

603

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.66

0.89

1.5

1.4

176.8

136.1

nmol/l

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

482

1.18

0.80

1.6

1.4

5.2

5.6

nmol/l

0.45

465

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2092

12684

1.03

0.79

2.5

2.2

5355.7

6040.6

u/l

0.43

745

5122

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

267

1.24

0.77

1.1

1.0

0.2

0.3

u/ml

0.32

149

(3001556) Androgen free Index in Serum or Plasma

313

1.22

0.76

1.5

1.2

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

2.09

0.74

3.6

6.6

14.8

1.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

314

1814

1.08

0.71

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.54

0.70

1.1

1.4

1.6

2.3

mmol/24h

0.92

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

282

1.22

0.70

1.0

1.1

1.9

2.8

u/ml

0.32

208

(40768793) Breast Pathology biopsy report

965

6319

0.96

0.69

1.4

1.3

—

(4281824)

510

3006

1.06

0.68

1.2

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3335

20422

1.02

0.67

1.2

127.8

146.6

iu/ml

1.88

1133

7925

(3020650) Glucose [Presence] in Urine

131

726

1.13

0.67

1.6

1.4

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

183

1.27

0.65

2.7

3.3

1608.0

94.6

pmol/l

0.46

(42870560) Thyrotropin [Units/volume] in Cord blood

167

1.28

0.63

1.0

9.0

8.4

mu/l

0.21

133

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.74

0.63

4.2

1.7

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

1.74

0.63

1.8

2.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

1.74

0.63

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

179

1.26

0.62

1.0

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

196

1.25

0.61

1.1

2.9

2.7

u/ml

—

(3020874) Milk IgE Ab [Units/volume] in Serum

313

1823

1.08

0.61

1.1

2.5

u/ml

0.01

108

498

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

270

1828

0.92

0.61

2.4

1.8

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

304

1769

1.08

0.61

1.1

6.2

4.2

u/ml

0.32

101

420

(3005593) Pancreatic islet cell Ab [Titer] in Serum

1.57

0.60

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

249

1.21

0.58

1.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.41

0.56

1.1

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.57

0.56

1.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.48

0.54

1.0

1.1

1146.7

2382.1

titre

—

(3003157) Bacteria [#/volume] in Mother's milk

0.61

0.53

5.0

6.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

333

1.17

0.53

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

184

1.23

0.51

1.1

7.4

8.1

u/ml

0.08

125

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.37

0.51

1.3

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

273

1598

1.07

0.50

1.1

1.0

0.7

u/ml

0.02

217

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

300

1.17

0.50

1.1

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

185

1.22

0.49

1.1

—

(3003577) Lead [Moles/volume] in Blood

209

1.20

0.47

1.4

0.2

umol/l

0.16

(3034274) Bile acid [Moles/volume] in Serum --fasting

696

4190

1.04

0.47

2.1

2.2

6.6

6.7

umol/l

0.09

518

3038

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

196

1322

0.93

0.45

1.8

1.9

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.43

0.43

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

283

1672

1.06

0.42

5.9

6.7

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.39

0.42

1.0

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

371

2211

1.05

0.41

1.8

1.4

0.9

g/l

0.35

366

2193

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2423

15461

0.98

0.40

1.1

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

713

4315

1.04

0.40

1.1

3.5

2.8

u/ml

0.53

278

2182

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.30

0.40

1.0

0.1

u/ml

0.09

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4712

29896

0.99

0.39

1.5

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

537

0.90

0.39

1.5

1.8

2.4

3.8

ug/l

0.62

329

(40761995) Spermatozoa Progressive [#/volume] in Semen

116

792

0.92

0.38

2.9

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

116

791

0.92

0.38

5.8

6.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

155

0.81

0.37

1.0

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.31

0.33

1.0

0.0

0.1

u/ml

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2433

15017

1.02

0.31

3.6

3.2

58.4

48.5

u/ml

0.82

2354

14518

(3007542) Rye IgE Ab [Units/volume] in Serum

155

1.17

0.30

1.1

1.0

0.8

0.3

u/ml

0.39

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.29

0.30

1.0

0.1

1.0

u/ml

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.75

0.30

3.9

5.6

0.2

mmol/l

—

(3040794) Aluminum [Moles/volume] in Urine

1.25

0.29

1.3

1.2

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

162

1.16

0.28

1.0

11.2

17.2

u/ml

0.86

133

(3033942) Copper [Moles/time] in 24 hour Urine

127

1.18

0.28

1.3

1.1

1.6

0.8

umol/24h

—

(3051101) Glucose [Moles/volume] in Cord blood

432

1.09

0.26

5.4

5.7

—

(3044336) Cobalt [Moles/volume] in Urine

1.20

0.25

2.8

2.2

11.5

28.0

nmol/l

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

100

0.81

0.24

1.0

0.1

u/ml

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

296

1.10

0.24

1.1

1.0

2.1

0.6

u/ml

0.38

159

(40762887) Creatinine [Moles/volume] in Blood

1.28

0.24

1.3

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

103

688

0.94

0.24

2.3

2.6

109.6

95.8

ng/l

0.39

358

(40758358) Immune stain study

118

1.17

0.23

1.0

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.80

0.23

1.0

1.4

0.2

u/ml

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

136

807

1.06

0.23

1.3

1.4

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.25

0.22

1.0

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.4

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.22

0.0

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

588

0.94

0.21

1.8

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.25

0.21

1.0

0.2

0.4

u/ml

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

299

1.09

0.21

1.1

1.0

11.4

2.1

u/ml

0.40

162

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.21

0.20

1.0

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

182

1097

1.04

0.18

1.3

1.4

597.5

602.7

mu/l

0.02

168

1047

(4038314)

228

0.91

0.18

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

214

1295

1.04

0.18

1.2

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

185

1121

1.03

0.15

1.3

1.4

72.4

73.1

0.27

171

1071

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.20

0.14

1.1

68.9

108.6

nmol/24h

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

202

1.09

0.14

1.1

1.2

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.87

0.14

1.0

2.0

0.3

u/ml

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

113

0.89

0.13

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

182

1171

0.97

0.11

1.8

1.9

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

423

2607

1.02

0.11

4.4

4.8

109.4

113.0

u/ml

0.03

108

828

(3015350) Toxocara sp Ab [Presence] in Serum

1.16

0.10

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

1.04

0.09

1.2

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.11

0.08

1.1

1.2

—

(3022670) pH of Venous cord blood

1.13

0.08

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.86

0.07

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.08

0.07

1.9

2.8

3.4

1.8

mu/l

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.08

0.07

1.6

1.0

2.7

2.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

456

1.03

0.07

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

152

970

0.98

0.06

2.8

3.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

348

0.97

0.04

1.0

—

(3022475) Manganese [Moles/volume] in Blood

182

0.96

0.03

1.2

1.3

—

(46235168) Fasting glucose [Moles/volume] in Blood

320

0.98

0.02

6.4

1.2

8.8

6.8

mmol/l

2.92

109

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

266

1656

1.01

0.02

1.3

1.4

5.8

5.6

mmol/l

2.15

245

1570

(3013139) Helicobacter pylori Ag [Presence] in Stool

2984

18718

1.00

0.02

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

1.08

0.02

1.1

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

431

0.99

0.01

1.1

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

196

0.99

0.00

1.0

0.1

0.2

u/ml

—

(3007700) Barley IgE Ab [Units/volume] in Serum

138

1.00

0.00

1.0

0.3

0.4

u/ml

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.92

0.00

1.2

1.1

147.9

142.9

mmol/24h

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.96

0.00

2.0

2.2

—

(3039179) Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid

0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.87

-0.00

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: PULM_PNEUMONIA_SEPSIS – COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints